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1. INTRODUCTION 
The Relevance of the Topic 
Cardiovascular diseases are the leading cause of death in the European Union. 
They cover a broad class of medical problems and disorders affecting the circulatory 
system (the heart and the blood vessels). They commonly stem from atherosclerosis 
(the abnormal build-up of plaque made of, among other materials, cholesterol or fatty 
substances deposited on the inside walls of arteries. Ischaemic heart disease (heart 
attacks) and cerebrovascular diseases (strokes) are considered to be the most common 
diseases affecting the circulatory system in humans [1].  
Currently, more than 6 million new cases of cardiovascular diseases are 
recorded in EU every year, and in Europe as a whole this number is in excess of 11 
million. In total, almost 49 million people live with CVD in the EU, which results in 
high costs to the EU economies – nearly €210 billion a year [2]. Of the total cost of 
CVD in the EU, health care costs account for approximately 53 percent (€111 billion), 
whereas productivity losses contribute 26 percent (€54 billion), and informal care of 
people suffering from CVD costs 21 percent of all the relevant expenses (€45 billion). 
The main risk factors for cardiovascular diseases are as follows: high blood 
pressure (annually, 15 percent more in Western Europe) [3], smoking (16 percent of 
deaths in adults over 30), just to mention a few [4]. Excessive alcohol consumption 
(which has recently been considered a major problem in Lithuania, too), high sugar 
consumption (the cause of 15 percent of deaths due to CVD), obesity (+5 percent in 
Lithuania during the last 5 years) [5], high cholesterol levels (closely linked to 
unhealthy lifestyles, overweight and diabetes), lack of physical activity, frequent 
stress and diabetes (expected to go 165 percent up globally in 2050) [6]. 
Almost half of the individuals who have had their extremity amputated due to 
a vascular disease die within 5 years. This is higher than the five-year mortality rates 
for breast cancer, colon cancer, and prostate cancer [7]. Nearly 55 percent of persons 
suffering from diabetes who have undergone a lower limb amputation will require the 
amputation of the other leg as well within 2–3 years [8]. 
The majority of limb amputations is caused by circulatory disturbances, such 
as vascular occlusions and strictures. Consequently, it is necessary to search for novel 
and more effective methods of eliminating vascular malformations. For this reason, 
various invasive and non-invasive ultrasonic devices are currently being used. 
However, given the depressing statistics, they are far from being sufficiently effective. 
The discovery of a modern and more advanced ultrasonic interventional 
vascular clearing methodology would enable saving not only the limbs of CVD 
patients and their lives but would also contribute to the wealth of the economies of 
Lithuania and Europe as a whole as this would allow saving lots of finances currently 
being spent on treating patients in non-effective ways, as well as nursing and taking 
care of them after they lose their ability to work. 
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Aim and Objectives of the Research 
The aim of the research is to investigate the effect of the active invasive 
ultrasonic vascular clearing systems on live human tissues and to use the relevant 
findings and the results obtained in the course of the research for the further 
improvement of the active members that are currently used in ultrasonic systems. 
In order to achieve the above stated aim, the following objectives were set: 
1. To accomplish comprehensive analysis of literature on the human 
cardiovascular system covering the currently known effects of ultrasound 
on human tissues, to collect data on various waveguides currently being 
used for the purpose of vascular clearing, and to analyze the blood vessel 
cleaning devices currently available on the market. 
2. To develop a multipurpose waveguide capable of operating in three 
directions (along axes x, y, and z) and suitable for restoring the 
functioning of the blood vessels in an interventional way. 
3. To develop a technique for the research of the cavitation process within 
fluids while mathematically modeling the waveguide of a newly designed 
structure operating within the tissue-confined fluid.  
4. To investigate experimentally the newly designed waveguide (operating 
as an active member of the ultrasonic vascular clearing system), to find 
out the effects it has on human tissues and the medium within which it is 
being operated (blood), and to determine the operational characteristics 
of the system under consideration.  
Methods and Means 
This work is carried out by using theoretical and experimental research 
methods. The theoretical studies were performed by using COMSOL 
MULTIPHYSICS computer software packages. The experimental studies for the 
performance of piezoelectric actuators were created in the Institute of Mechatronics, 
Kaunas University of Technology. The experimental results were obtained by using 
the most up-to-date available non-contact laser measuring equipment. 
Research Novelty 
1. A unique waveguide of an innovative shape has been developed; 
2. A dynamic model and a computational methodology of the unique 
waveguide featuring an innovative shape has been created; 
3. The effect of cavitation caused by the ultrasound on human tissues and the 
medium within which it is being operated (namely, blood) has been 
examined. 
 
 
 
 
  
 
9 
 
Practical Value 
An innovative waveguide of a unique shape has been designed for invasive 
clearing of blood vessels capable of generating the cavitation flow by means of 
inducing mechanical multidimensional vibrations of ultrasonic frequency. The 
waveguide under consideration is used within the ultrasound system for the 
elimination of vascular disorders in humans. The information gathered while 
preparing the thesis was used for the research in the framework of the joint KTU and 
the Lithuanian University of Health Sciences project “Go-SMART” funded by 
Research Council of Lithuania, Project No. MIP-097/15. 
Work Results Submitted for Evaluation 
1. The experimental trials and the discovered values of the operating 
characteristics of the mechanical ultrasound apparatuses fitted with the 
waveguide of a unique shape; 
2. The calculation of the effect stemming from waves caused within the 
tissue-confined body fluid during the operation of the waveguide;  
3. Experimental trials of the ultrasound effect on live human tissues. 
Work Approval 
The scientific research results and publications focused on the topic of this 
doctoral thesis were presented in 9 international scientific conferences, published in 2 
international journals having an Impact Factor as well as in 6 other publications listed 
in the main journal of the Institute for Scientific Information (ISI). Two different 
scientific inventions were patented in Lithuania.  
Scope of the Dissertation 
The dissertation consists of an introduction, four parts, general conclusions, a 
bibliography of 99 sources and a list of the author’s scientific publications on the 
dissertation topic. The dissertation volume is 116 text pages and 14 pages of annexes. 
Acknowlegements 
The autrhor of the dissertation would like to thank dear friends prof. dr. V. 
Jūrėnas and habil. dr. V. Garalienė, as well as prof. dr. V. Veikutis for scientific advice 
in the course of the preparation of the doctoral dissertation. 
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2. PROBLEM ANALYSIS AND FORMULATION OF THE TASKS 
2.1. The Blood Circulatory System of the Human and Anatomy of the Vessel 
The blood circulatory system (also known as the cardiovascular system) 
delivers nutrients and oxygen to all the cells of the body. It is comprised of the heart 
and the blood vessels that are deployed throughout the entire body. The arteries carry 
blood away from the heart, whereas the veins return it back to the heart [9]. The system 
of blood vessels might be compared to a tree: the main artery (called the aorta) being 
similar to a tree trunk branches into large arteries that further lead to smaller and 
smaller vessels. The smallest arteries end in a network of tiny vessels that comprise 
the so-called capillary network. 
The human body contains two blood circulatory systems that are 
interconnected: the  systemic circulation provides organs, tissues and cells with blood 
that carries oxygen as well as other vital substances. The pulmonary circulation is 
where the fresh oxygen enters the blood as we breathe in, and simultaneously carbon 
dioxide is released from the blood [10]. 
Blood starts circulating when the heart relaxes between two heartbeats: blood 
flows from both atria (the upper two chambers of the heart) into the ventricles (the 
lower two chambers) which then expand. The phase that follows is called the ejection 
period. During the ejection period, both ventricles pump the blood into the large 
arteries. 
In the systemic circulation, the left ventricle pumps oxygen-rich blood into the 
main artery (aorta). The blood flows from the main artery to larger arteries first, then 
to smaller arteries, and, finally, reaches the capillary network [11]. In the capillary 
network, oxygen, nutrients and other vital substances are released from the blood, and 
carbon dioxide as well as waste substances are taken on. The blood, being low in 
oxygen, is now collected in veins and flows to the right atrium and into the right 
ventricle [12]. 
Then, pulmonary circulation starts: the right ventricle pumps the blood low in 
oxygen into the pulmonary artery which branches off into smaller and smaller arteries 
and capillaries. The capillaries form a fine network around the pulmonary vesicles 
(grape-like air sacs at the end of the airways). This is where carbon dioxide is released 
from the blood into the air contained in the pulmonary vesicles, and fresh oxygen is 
supplied to the bloodstream. When we make a breath out, carbon dioxide is removed 
from our body [12]. Oxygen-rich blood flows through the pulmonary vein and the left 
atrium into the left ventricle. With the next heart beat, a new cycle of systemic blood 
circulation starts. 
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Fig. 1. The cardiovascular system [13]. 
All the blood vessels can be grouped into three major types as 
follows: arteries, capillaries, and veins. As the heart contracts, it forces blood to leave 
the ventricles and flow into the large arteries. Blood then moves further to smaller 
arteries successively, until it finally reaches the smallest branches, the so-called 
arterioles, which feed into the capillary beds of organs and tissues. Blood drains from 
the capillaries into venules, the smallest veins, and then into larger veins that merge 
and ultimately empty into the heart. If all the blood vessels contained in the human 
body were stretched out, these would be 100,000 km long [14]. 
Arteries carry blood away from the heart while forming smaller and smaller 
divisions, thus arteries are said to ‘branch’. In contrast, veins carry blood towards the 
heart and are said to ‘merge’ into larger and larger vessels approaching the heart. In 
the systemic blood circulation, arteries always carry oxygen-rich blood, and veins 
always carry blood low in oxygen [15]. The opposite is true for the pulmonary 
circulation. The arteries, defined as the vessels leading away from the heart, carry 
blood low in oxygen to the lungs; whereas the veins carry oxygen-rich blood from the 
lungs to the heart. Capillaries are the only blood vessels that have intimate contact 
with the tissue cells in the human body. Consequently, they are responsible for serving 
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cellular needs. Any exchanges between the blood and tissue cells occur primarily 
through the capillary walls that are thin. 
The walls of any blood vessel (except for the smallest ones) have three layers, 
the so-called tunics, that surround a central blood-containing space, which is referred 
to as the vessel lumen [16]. 
The innermost tunic is called the tunica intima. The tunica intima contains the 
endothelium which is the simple squamous epithelium, and it lines the lumen of all 
the vessels. The endothelium is continuous with the endocardial lining of the heart. 
Its flat cells fit closely together thus forming a slippery surface that minimizes friction 
so that blood could move smoothly through the lumen. In vessels larger than 1 mm in 
diameter, a subendothelial layer consisting of a basement membrane and a loose 
connective tissue supports the endothelium [17]. 
The middle tunic, called the tunica media, is mainly circularly arranged smooth 
muscle cells and sheets of elastin. The activity of the smooth muscle is regulated by 
sympathetic vasomotor nerve fibres of the autonomic nervous system and chemicals. 
Depending on the body’s needs at any given moment, regulation causes either 
vasoconstriction (decrease in the lumen diameter) or vasodilatation (increase in the 
lumen diameter). The activities of the tunica media are critical for the regulation of 
the circulatory system because even very small changes in the vessel diameter have a 
huge influence on the blood flow and the blood pressure. Generally, the tunica media 
is the bulkiest layer in arteries, and it bears the chief responsibility for maintaining the 
blood pressure and the proper blood circulation [18]. 
 
Fig. 2. Generalized Structure of Blood Vessels [18]. 
The outer layer of a blood vessel wall is called the tunica externa. It is mainly 
comprised of collagen fibres that protect and reinforce the vessel, and anchor it to the 
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surrounding structures [19]. The tunica externa contains nerve fibres, lymphatic 
vessels, and elastic fibres (in large veins). In large vessels, the tunica externa contains 
a structure known as the vasa vasorum – literally, ‘vessels of vessels’ – that nourish 
the external tissues of the blood vessel wall. The interior layers of blood vessels 
receive nutrients directly from the blood carried in the lumen. 
2.2. Vascular Disease 
Vascular Disease is the term describing blood vessel diseases. When a disease 
occurs in the arteries, it is called an arterial disease. Veins return blood back to the 
heart from all the parts of the body. When a disease occurs in the veins, it is called a 
venous disease.  
Atherosclerosis is a disease, in which, plaque tends to build up on the inside of 
the arteries (Fig. 3). Over time, this plaque build-up hardens around the artery walls 
thus narrowing the blood flow to the organs and various parts of the body. As organs 
do not receive blood rich enough in oxygen, they cannot function properly. 
Furthermore, blood clots often form around plaques. Sometimes, the plaque or a clot 
can break loose and travel to smaller arteries where it blocks the blood flow. In 
addition, a plaque can rupture [20]. Such blood flow blockages and plaque ruptures 
can lead to serious problems including, but not limited to, heart attacks, strokes and, 
in the worst-case scenario, death. There are many factors that contribute to causing 
atherosclerosis, such as smoking, high cholesterol level, diabetes, etc. Atherosclerosis 
can affect almost any artery. In many cases, it involves multiple arteries at the same 
time. It is commonly found in the coronary or heart arteries, the carotid or neck 
arteries, and the leg arteries. Atherosclerosis can also occur in the aorta, the largest 
artery of the body responsible for carrying blood from the heart to the chest, abdomen 
and legs. In a severe case of atherosclerosis, an artery may become fully blocked, 
resulting in ischemia – a restriction in oxygenated blood supply to any muscle group, 
organ or tissue. It is very common for ischemia to result in heart attacks and strokes 
[21]. 
 
Fig. 3. Atherosclerosis [22]. 
Some of the diseases that can stem from atherosclerosis are as follows [23]: 
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• Carotid Artery Disease is diagnosed when the major arteries in the neck, called 
the carotid arteries, become narrowed or blocked. These arteries are responsible 
for the blood supply to the brain. Significant artery narrowing leads to the 
increased risk of plaque or a clot breaking loose and travelling to the brain which 
will ultimately cause a stroke; 
• Coronary Artery Disease (CAD) occurs when plaque builds up inside the 
coronary or heart arteries. Narrowing or full blockage of coronary arteries 
prevents oxygen-rich blood from reaching the heart. Sometimes, this causes chest 
pain which is called angina (pronounced as an-JI-nuh or AN-juh-nuh); however, 
in severe cases, it results in a type of heart attack called myocardial infarction; 
• Mesenteric Artery Disease refers to the condition in which the major arteries 
carrying blood to the intestines become narrowed or blocked. Its symptoms, 
among others, include abdominal pain after eating, blood in the stool, and loss of 
weight.  
• Peripheral Arterial Disease (PAD) is diagnosed when the leg arteries become 
narrowed or blocked. Such a condition is also known as poor circulation or 
peripheral vascular disease. In case of insufficient blood flow to the legs and feet, 
patients diagnosed with PAD can experience leg pain, ulcers or sores. In some 
cases, patients with PAD suffer no symptoms whatsoever. However, in extremely 
severe cases, peripheral arterial disease, also known as a critical limb ischemia, 
can even require an amputation of the limb or at least a part of it.  
• Renovascular Disease is a progressive condition in which renal arteries 
responsible for the blood flow to the kidneys become narrowed or blocked. 
Atherosclerosis of renal arteries can cause high blood pressure or kidney failure.  
• Vertebrobasilar Insufficiency is a disorder characterized by poor blood flow to 
the posterior portion of the brain. Symptoms of narrowed vertebral arteries may 
include blurred or double vision, dizziness, and lack or loss of coordination or 
imbalance. Vertebrobasilar insufficiency can also cause drop attacks, or sudden 
and spontaneous falls while standing or walking. 
Aneurysm is a balloon-like bulge in the artery which occurs due to a weakening 
in the artery wall (Fig. 4). In most of the cases, aneurysms occur in the aorta, the 
largest artery in the body, carrying blood from the heart to the chest, abdomen and 
legs. However, aneurysms can also occur in brain and leg arteries. A ruptured 
aneurysm is an emergency which requires immediate medical attention. Progressive 
weakening of the aortic wall causes the so-called Aortic Aneurysm. This may cause 
bulging or ballooning of the vessel, which, if not treated properly, may continue to 
grow and even rupture. An aneurysm in the abdomen is known as abdominal aortic 
aneurysm (AAA, or triple A), whereas an aneurysm in the chest is called a thoracic 
aortic aneurysm [23]. 
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Fig. 4. An Aneurysm [23]. 
Venous Thrombosis is a blood clot that forms in any of the veins (Fig. 5). 
Venous clots can block the blood flow through the vein, or can also travel to any part 
of the body. There are many factors that are considered to increase the risk of 
developing venous clots including, but not limited to, various leg traumas, injuries to 
the veins, a recent surgery or hospitalization, being overweight, and prolonged body 
immobility, such as a long airplane ride or bed rest [24]. Taking birth control pills, 
having cancer, and even pregnancy can also lead to the increased risk of blood clots 
formation in the veins. Moreover, people who once have had a blood clot face a higher 
chance of having another one. Clots can occur in both the arm and leg veins, however, 
it is more common for blood clots to form in legs. In most severe cases, blood clots 
are treated with blood thinner drugs called anticoagulants. Anticoagulant drugs 
decrease the blood’s ability to clot to a controlled degree. They prevent clots from 
getting bigger, and also prevent the formation of new ones [25]. 
 
Fig. 5. Venous Thrombosis [26]. 
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Deep Vein Thrombosis (DVT) is the condition in which blood clots form within 
the deep veins of the arms or legs (Fig. 6). As for the legs, DVT is diagnosed when a 
clot forms in one of the deep calf or thigh veins while blocking blood flow and causing 
pressure to build up in the vein. Symptoms include pain and swelling in one or both 
legs. DVT is rather rarely found in the arms; however, it occurs most often in the large 
veins called the axillary and subclavian veins. Symptoms of arm DVT include swelled 
and painful arms, prominent veins that can be clearly seen through the skin, and 
changes in the skin color [27]. 
 
 
Fig. 6. Deep Vein Thrombosis [28]. 
DVT can lead to a serious complication called Pulmonary Embolism (PE). It is 
diagnosed when some or all of the DVT breaks loose from its original location in a 
vein and is moved through the heart into the lungs. The most common symptoms of 
PE include chest pain, difficulty breathing, and heart palpitations or a racing heartbeat. 
Again, pulmonary embolism is an emergency and requires immediate medical 
attention [29].  
Superficial Vein Thrombosis (SVT) refers to a blood clot in a surface vein of the 
arm or the leg, close to the skin. Blockages in the superficial veins are not as serious 
as those in the deep veins, but they may still cause swelling and discomfort [30]. 
Veins return blood from the arms and legs back to the heart in order for the 
lungs to resupply it with oxygen. Veins contain special valves that prevent blood from 
flowing in the opposite direction. In case these valves fail to work properly, blood can 
flow backwards down the veins and pool in the lower leg. This may cause veins to 
enlarge and can further result in leg swelling, aching and burning, skin color changes 
as well as leg ulcers [31]. 
Varicose Veins refer to the visibly bulging veins that mildly protrude or do not 
protrude above skin in the thigh or calf. Generally, varicose veins are larger than 3 mm 
in diameter. They develop due to the weakness of the vein wall and because the valves 
no longer function as they are supposed to. Sometimes, varicose veins form entire 
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families. There are two other conditions that are often mistakenly taken for varicose 
veins, namely, spider veins and reticular veins. Spider veins, also called 
teleangiectesia, refer to the tiny veins that can be easily seen but cannot be felt. 
Reticular veins are larger than spider veins but smaller than varicose veins [32]. 
Lymphedema is a disorder of the lymphatic blood vessels which leads to 
Lymphedema is a disorder of the lymphatic blood vessels that leads to severe swelling 
of one or both of the legs or arms. In some cases, lymphedema is caused by some 
damage of the lymphatic vessels, for example, this may happen among women who 
have received surgery in the course of the treatment for breast cancer. Sometimes, 
lymphedema is found to have run in families and is also diagnosed in children or 
young adults [33]. 
Vasculitis is an inflammation of the blood vessels that occurs when the body’s 
immune system mistakenly attacks the blood vessels causing them to become 
inflamed. As a result of such inflammation, the blood vessels can become damaged, 
and this may lead to the narrowing or blockage of blood flow or aneurysms of the 
blood vessels. Vasculitis can affect any of the body’s blood vessels [34]. 
Raynaud’s phenomenon refers to a disorder in which arteries tend to go into 
spasm for brief periods. The contraction or narrowing of the blood vessels (called 
vasospasm) leads to decreased blood flow to the fingers and toes. In some cases, it 
can affect the nose, ears, nipples and lips. Due to the reduced blood flow, the  color 
of the affected area may change. For example, some patients report that their fingers 
turn blue, white and/or red. It is common for a vasospasm to occur in response to cold, 
but it can also be triggered by stress. Mild Raynaud’s phenomenon is commonly found 
among young women. Although severe Raynaud’s phenomenon is rare, it may even 
lead to ischemia of the hands or feet and non-healing sores [35]. 
Compression Syndromes occur when blood vessels are narrowed or compressed 
by bones, muscle, or other body tissues. With Thoracic Outlet Syndrome (TOS), blood 
vessels and nerves of the arms are compressed as they leave the chest cavity by the 
surrounding bones and muscles. If the nerves are affected, TOS may cause pain or 
numbness in the arms with certain movements. If the blood vessels are affected, it 
may cause arm swelling or a blood clot. With Popliteal Entrapment Syndrome, the 
compression of the popliteal artery or the popliteal vein at the back of the knee by the 
calf muscles may cause leg pain with exercise or a blood clot in the leg [36]. 
Some of the diseases listed in Chapter 1.3 are healed while applying ultrasound 
and the process that ultrasound creates, i.e., cavitation. Therefore, it is important to 
understand how ultrasound is applied in the field of modern medicine. 
2.3.  Application of Ultrasound in Medicine  
Ultrasound refers to a high frequency (0.02 to 200 MHz) acoustic wave that 
transfers energy in a gas, liquid or solid medium [37]. In gases and liquids, the 
longitudinal waves of sound mainly propagate, whereas, in solid bodies, both 
transverse and longitudinal sound waves can be transmitted. The speed of ultrasound 
transmission depends on the density and elasticity or the stiffness of the medium. The 
ultrasonic wave occurs due to the rhythmic oscillations of the particles (molecules and 
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atoms) in the medium that cause the medium to get denser and to bend (due to particles 
getting closer and farther from each other, respectively), because of which, the 
pressure tends to increase and decrease, respectively. The vibrations at frequencies 
higher than 20 kHz are called ultrasonic, or the ultrasound. When propagating, the 
sound pressure oscillations transfer kinetic energy [38]. The ultrasound energy 
absorbed by tissues is converted into heat. The ultrasound absorption (conversion into 
heat) is described by means of the Thermal Index (TI). When TI=1, the temperature 
in the medium under consideration rises by 1 degree, when TI = n, by n degrees. TI is 
mainly dependent on the characteristics of the tissue.  
The energy transported in an ultrasound wave is usually characterized by 
acoustic intensity I which is defined as the energy transmitted per time unit (usually, 
1 s) and per area unit (usually, 1 cm2) in the direction normal to the area under 
consideration. In the field of medical ultrasound, the intensity is measured in W · 
cm−2.  
In general, the ultrasound can be either continuous or pulsed. The continuous 
ultrasound is the regime in which the generated ultrasonic waves are propagating at 
the constant amplitude, with no pauses, under constant frequency. On the other hand, 
pulsed ultrasound is the intermittent regime, involving pauses, however a recurrent 
one.  Ultrasound working regimes are shown in Fig. 7. 
 
 
Fig. 7. Continuous and pulsed ultrasound regimes [39]. 
Ultrasonic energy can be a potent means enabling to achieve the desired 
biological effects. Having sufficient knowledge of the etiology and exposimetry, it is 
possible to plan some bioeffects for therapeutic purposes or to avoid other ones in 
diagnostic applications [40]. As for the therapy, ultrasound can induce the desired 
effects not only by the way of heating but also through certain non-thermal 
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mechanisms such as gas body activation, ultrasonic cavitation, mechanical stress, and 
other undetermined non-thermal processes [41]. 
Ultrasound-induced heating stems from the absorption of ultrasonic energy by 
biological tissue. By using ultrasound for diagnostic purposes, the temperature 
elevations and the potential for bioeffects are kept relatively low or negligible [42] by 
carefully following the described indications for use while applying the ALARA (As 
Low As Reasonably Achievable) principle, limited temporal average intensities, and 
generally short exposure times. On the other hand, therapeutic applications of 
ultrasonic heating therefore either involve longer durations of heating with unfocused 
beams or use higher-intensity (than for diagnostic purposes) focused ultrasound. The 
use of unfocused heating, for example, in physical therapy, to treat highly absorbing 
tissues, such as a bone or a tendon, can be moderated to produce enhanced healing 
without an injury [43]. Alternatively, the heat can be concentrated by focused beams 
until the tissue has been coagulated for the purpose of tissue ablation. Ultrasonic 
heating, which can lead to irreversible tissue changes, follows an inverse time-
temperature relationship. Depending on the temperature gradients, the effects of 
ultrasound exposure can include mild heating, coagulative or liquefactive necrosis, 
tissue vaporization, or all the three effects [44]. 
Recently, a series of tests have been undertaken for the purpose of evaluating 
the blood vessel endothelial function because scholarly studies have shown that 
endothelial dysfunction can be considered to be an independent risk factor in patients 
with the suspected coronary insufficiency [45, 46]. A damaged endothelium is no 
longer able to release endothelium-dependent vascular smooth muscle relaxing 
factors. For this reason, it is still necessary to explore various tools that can potentially 
restore the endothelial function. Currently, ultrasound has also been widely applied in 
body’s circular system diagnostics. However, there is lack of researches regarding the 
ultrasound’s effect on the physiological functions of endothelium and the smooth 
muscles associated with the vessel contraction and relaxation. 
2.4. The Process of Cavitation 
Cavitation is defined as the formation of vapor cavities and small liquid-free 
zones (also named as ‘voids’) within a liquid body. There are a number of ways to 
force a cavitation to appear. The aim of this chapter is to describe the most common 
of these techniques. 
2.4.1. Acoustic Cavitation 
Acoustic cavitation refers to the formation (expansion) of bubbles during the 
negative phase of the acoustic cycle when liquid pressure is below the critical limit. 
When acoustic pressure achieves a positive value, the expansion of a bubble is slowed 
down, and, finally, the bubble bursts. 
The term ‘stable cavitation’ refers to the condition in which the speed of bubble 
expansion under negative pressure is equal to the period of collapse in the positive 
portion of the acoustic cycle [47]. It is worth noting that the formation of stable 
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bubbles is not influenced by the process when the vibration-induced pressure field 
increases in volume more than it contracts after bursting.  
2.4.2. Tension 
The simplest way to stretch out a liquid is to pull some portion of it. Such 
tension of a liquid can be influenced by its own weight. When studying the effect of 
the liquid weight, in 1962, Huygens [48] was the first to record the existence of the 
negative pressure in a liquid. On the one side, an open column semi-filled with water 
was placed into a larger tank, and then all the remaining air was sucked out of it. This 
led to the observation that when the air above the larger tank hass been sucked out, 
the water remains ‘pending’ in the smaller container turned upside-down. At the top 
of the water column of height h, Psat – ρgh, where ρ represents the density of water, 
and g is the force of the Earth’s gravity. 
When an air bubble is injected into a water column, the bubble shall rise 
upwards, and the water column falls down, respectively. The experiment was 
afterwards repeated; however, the container was filled with mercury instead of water. 
Other ways to ‘pull’ a liquid also exist, and one of them is to mechanically 
increase the liquid volume by using special bellows or to heat it after compressing, 
and then to remove the pressing element of the apparatus. These two ways were the 
most popular ones for a rather long period of time while making bubble chambers 
where particles were recorded as carrying an extremely high energy and causing 
cavitation.  
2.4.3. The Method of Bertholet 
While using the method of Bertholet, to induce cavitation, it requires a container 
to be filled with water and then sealed. If a bubble of gas (air) persists, the entire 
structure is heated until the gas bubble has dissolved completely. The density of the 
liquid is found based on the temperature of bubble dissolution Td. 
Afterwards, the container is cooled down while decreasing its pressure to the 
negative value (i.e., cooled down to the sufficiently low temperature). At temperature 
Tcav, cavitation occurs, and the fluid restores its original condition (the ambient 
temperature). Bertholet used the cavitation-induced change in volume for measuring 
the size of the cavitation bubble. 
2.4.4. Inclusions 
Water contained in extremely small (10 to 100 micrometers) vessels is also 
found in the nature, often trapped inside various crystals. Roedder used such 
microscopic fluid inclusions for studying the equilibrium of ice crystals and water 
(fluid). His research started from a fluid with vapor inclusion. When freezing 
inclusions, vapor was found to disappear due to the increase in the ice volume. When 
such a specimen was heated, the vapor was observed not to recover, and the negative 
pressure was found to increase with the system approaching the melting point. 
At a later date, the method of Bertholet was applied while using synthetic 
materials as inclusions instead of vapor. Primarily, the experiments involved salt 
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solutions of low concentrations [49]. Crystals of quartz, calcite and fluorite were 
processed in distilled water heated to 300o to 400o. Afterwards, cleft crystals were 
placed into tubes made of a silver and lead compound together with the known amount 
of absolutely pure water. The entire container was then vacuumed. During vacuuming, 
any fractures present in crystals were filled with water depending on the temperature 
and pressure applied during the process. 
Hereafter, the specimens were studied by using the method of Bertholet. The 
water bubbles remaining inside the inclusions were observed to disappear when 
heated to temperature Td. When freezing the specimen, the water parameters changed 
gradually until the occurrence of cavitation. The derivation of Pcav parameter was 
based on the EOS multi-parameter dependent on the pressure of the stable fluid.  
2.4.5. Centrifuging 
For the first time applied by Reynolds, this method involves rotation of the 
water present inside a specific container at a high speed [50]. Negative pressure is 
created on its axis due to eccentric power.  
2 21
2
oP P r        (1.1) 
Where P0 denotes the pressure outside the container; ρ represents the water 
density. 
 
Ultrasonic cavitation and gas body activation are closely related mechanisms 
that depend on the rarefactional pressure amplitude of ultrasonic waves. Ultrasound 
transmitted into a tissue may have rarefactional pressure amplitudes of several 
megapascals (Fig. 8). This tensile stress is supported by the medium. For example, a 
2 MPa rarefactional pressure, which is common even for diagnostic ultrasound, 
represents a negative tension 20 times the atmospheric pressure (i.e., 0.1 MPa) [51]. 
This high rarefactional pressure can act to initiate cavitation activity in a tissue when 
suitable cavitation nuclei are present or directly induce the pulsation of pre-existing 
gas bodies, such as those occurring in lungs and intestines, or with ultrasound contrast 
agents. Cavitation and gas body activation primarily cause local tissue injury in the 
immediate vicinity of the cavitational activity, including cell death and the 
hemorrhage of blood vessels [52]. 
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Fig. 8. Ultrasonic cavitation [51]. 
Other potential mechanisms for biological effects of ultrasound include the 
direct action of the compressive, tensile, and shear stresses. In addition, there are 
second-order phenomena that depend on the transmitted ultrasonic energy. They 
include radiation pressure, forces on particles, and acoustic streaming. What regards 
the high-power or high-amplitude ultrasound which is intended for therapy, several 
different mechanisms may be contributing simultaneously to the total biological effect 
of the treatment. In addition to direct physical mechanisms for bio-effects, there are 
secondary biological, physical, and physiologic mechanisms that cause further effects 
on the organism. Some examples are vasoconstriction, ischemia, extravasation, 
reperfusion injury, and immune responses [53]. In some cases, these secondary effects 
tend to be greater than the direct insult from the ultrasound. 
 
2.5. Dynamics of the Cavitation Bubble 
2.5.1. Dynamics of the Spherical Bubble 
Investigation of spherical cavitation bubbles has no direct implications for the 
attempts to explain the cavitation erosion as bubbles present in sufficient vicinity to 
the walls to cause harm will always collapse aspherically. Despite that, such 
investigation provides a sound basis for interpreting the data obtained for 
asymmetrical collapse of bubbles in the non-Newtonian fluids. Up to date, it is the 
only way available for comparison of the test results and the theory. 
A simple way to generate a single bubble in the fluid is to focus a low-pulsed 
laser light to a specific point on the fluid surface. Depending on the size of the focus 
point, the laser transverse mode, the pulse duration and the intensity of the light, a 
single drop or several small ‘drops’ of the fluid get rapidly heated (in nano-, pico- and 
femto-seconds). 
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Fig. 9.  Dynamics of the cavitation bubble in water and the respective pressure signal 
measured at a distance of 10 mm to the laser focus when laser pulse energy EL = 10mJ. 
Fig. 9 shows a high-speed photography image of the dynamics of a bubble 
generated by a laser in water as well as the respective hydrophonic signals at a distance 
of r = 10 mm to the laser focus when the laser pulse energy equals EL = 10mJ. The 
interval time between shots is 20 µs. The laser light is emitted from below. The 
hydrophonic signal is recorded at the same time as the images showed in the above 
figure. Over a certain period of time, the movement of the laser wave causes the 
formation of a shock wave. The resulting difference between the hydrostatic and the 
dropping internal pressure of the bubble determines a significant increase in the 
volume of the bubble, and finally leads to its burst. During this process, the kinetic 
energy of the fluid is converted into the potential energy of the bursting bubble. 
The energy contained in the bubble is described as follows:  
3
max
4
( )
3
BE p p R

         (1.2) 
It is dependent on the radius and maximum size Rmax of the bubble as well as 
on the difference between the hydrostatic pressure and vapor pressure pv.  
The bubble expanded to its maximum size will collapse again due to the static 
pressure of the surrounding fluid. The volume of the bubble then decreases to a very 
small size; however, at the moment of its collapse, extremely high pressure is created 
that may exceed even 1 GPa [54].  
2.5.2. Dynamics of Aspherical Bubble 
The dynamics of the bubbles being generated is mainly influenced by the 
physical limits of the bubble movement and the features of the fluid within which this 
bubble occurs. When a bubble is generated in the vicinity of a wall (a physical barrier), 
its burst will be asymmetric and linked to the formation of several high-speed water 
streams generated around it where the entire energy of the bubble is concentrated [55]. 
At the moment of the bubble burst, such water streams strike the wall which is 
present in close vicinity. When a bubble happens to burst in between two walls 
standing next to each other, they are struck by two such water streams. 
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2.6. Patented Ultrasound Devices for the Intravascular Thrombus 
Decomposition 
Thrombolysis accelerated by ultrasound involves the breaking down or 
‘melting’ of blood clots that can be found in the leg arteries or veins. In the past, it 
was common practice to treat blood clots by simply giving blood thinners to be 
consumed by the patient either orally or injected intravenously. As a result, over two 
to four months, those blood clots can be expected to disappear. However, recently, 
new methodologies have been under development that use ultrasound energy along 
with thrombolytics to facilitate and accelerate the process of thrombolysis. 
A blood clot is generally made up of different elements, such as fibrin, weaved 
together into a net-like structure. Acoustic energy is known to generate a pressure 
wave that enables the disruption of the cross-linking of the fibrin. The ultrasound 
energy also helps loosening up the fibrin cross-links while creating a way for the 
thrombolytic to get into the clot. The ultrasound energy does not actually break up the 
clot. It only alters the shape of the fibrin network. As a result, the clot becomes more 
porous, which makes it easier for the drug to get inside the clot and have a more 
powerful effect there instead of just being dripped in around it (unfortunately, that is 
is how the old catheter systems function). In medical practice, various catheters have 
been used for delivering the drug for many years, but the only reason they were good 
for was just getting the drug to the leg. Meanwhile, ultrasound-accelerated 
thrombolysis allows the drug to get into the clot directly. 
Ultrasound system with pathfinding guidewire. A system is designed to enable 
the crossing of completely occluded blood vessels. The system is comprised of a 
pathfinding guidewire that is coupled to the distal end of an ultrasound catheter. The 
distal section of the pathfinding guidewire functions as a narrow extension of the distal 
end of the catheter. This way, the ultrasound energy is effectively transmitted, which 
allows to traverse the occlusions [56]. Once the distal section of the guidewire has 
successfully crossed the occlusion, the distal end of the catheter can be advanced over 
the distal section of the guidewire and against the occlusion to remove the occlusion 
(see Fig. 10). 
 
Fig. 10. An ultrasound system with the pathfinding guidewire, where 1 is the guidewire; 2 is 
the waveguide; 3 is an occluded blood vessel [56].. 
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Ultrasonic transmission guidewire. The ultrasonic angioplasty transmission 
guidewire has reduced the cross-sectional diameter at some areas in order to improve 
its flexibility and to compensate for the degradation of the longitudinal displacement 
stemming from acoustic losses along the length of the guidewire. The core of a 
guidewire is made of ultrasonic transmission material. The guidewire also has a non-
metalic outer jacket which surrounds the usable portion of the elongated shaft (see 
Fig. 11). The outer jacket is formed of a shrink tubing. Threads are disposed at the 
proximal end. These threads are configured to be connected to a connecting device 
for an ultrasound transducer. The distal end has a smooth ball tip in order to avoid any 
traumas during the application of ultrasound energy to the biological tissue [57]. In 
one embodiment, the guidewire is formed of stainless steel, whereas, in another one, 
it is formed at least partially of a super-elastic metal alloy, and in one case it is formed 
at least partially of a shape memory alloy that exhibits super-elastic properties when 
in its martensitic state. In one preferred embodiment, the guidewire is formed of a 
nickel and titanium alloy. 
 
Fig. 11. Ultrasonic transmission guide wire, where 1 is the distal head; 2 is the radio opaque 
marker for use in locating the distal tip during in vivo procedures; 3 is the ultrasonic 
transmission wire [57]. 
Guidewire system for RF recanalization of vascular blockages. A system for 
recanalizing an occluded blood vessel is comprised of a centering catheter employed 
to center an ablative guide wire within the blood vessel as the guidewire traverses the 
occlusion. The centering catheter is made of a catheter body with an operative lumen 
through which the ablative guidewire is slidingly disposed. The centering catheter 
further includes a distally disposed centering mechanism that, when activated, centers 
the ablative guidewire within the blood vessel as it traverses the occlusion. The 
centering mechanism can involve various embodiments including a single inflatable 
balloon or a segmented inflatable balloon which is in fluid communication with the 
inflation lumen. An airless preparation lumen may be disposed within the inflation 
lumen to make it easier to center the catheter preparation [58]. The ablative guidewire 
is covered with insulation that is preferably made of heat shrink tubing which is 
stretched prior to or concurrently with the heating process. The ablative guidewire 
includes a distal ablation tip of the atraumatic structure and at least one discontinuous 
feature for creating high current densities to make tissue ablation more efficient (see 
Fig. 12). 
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Fig. 12. A guide wire system for RF recanalization of vascular blockages, where 1 is a blood 
vessel; 2 is a waveguide; 3 is a balloon; 4 is the targeted thrombus [58]. 
Ultrasonic resonator (Fig. 13). An ultrasonic resonator is comprised of a wire 
member with an elongated shaft that has a proximal end and a distal end. The filler 
material is disposed within the proximal end. A crimp screw is used with an annular 
end and a threaded end. Its annular end is adapted to receive and fixedly secure the 
proximal end of the wire member. The annular end being crimped after the proximal 
end of the wire member is inserted within the annular end of the crimp screw. The 
resonator includes an ultrasonic transducer specifically adapted to receive the 
threaded end of the crimp screw. The ultrasonic transducer is operatively connected 
to an ultrasonic generator [59]. 
 
Fig. 13. Ultrasonic resonator, where 1 is the waveguide; 2 is the hole for the waveguide; 3 is 
the crimp screw [59]. 
Apparatus and method for an ultrasonic medical device with improved visibility 
in imaging procedures. The invention under consideration here refers to the apparatus 
and the operation method for an ultrasonic medical device with improved visibility in 
imaging procedures. This medical device has an elongated probe which at 
predetermined location(s) has a material of high radiopacity. The material of high 
radiopacity is able to withstand series of vibrations of the elongated probe [60]. Once 
the probe has been inserted into a body, this material of high radiopacity allows the 
elongated probe to be visualized in imaging procedures (see Fig. 14). The present 
invention covers a method of improved visibility of an ultrasonic medical device 
during a medical procedure by engaging a material of high radiopacity into a small 
diameter elongated probe wherein the material of high radiopacity engages the probe 
in at least one predetermined location. 
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Fig. 14. Apparatus and method for an ultrasonic medical device with improved visibility in 
imaging procedures, where 1 is the coupling; 2 is the wireguide; 3 are the anti-nodes; 4 are 
the nodes [60]. 
Steerable ultrasound catheter. Ultrasound catheter devices and respective 
application methods offer enhanced disruption of blood vessel blockages. Such 
devices usually involve an elongated flexible catheter body with one or more lumens, 
an ultrasound transmission member extending longitudinally through the catheter 
body lumen, and a distal head coupled with the transmission member that is positioned 
adjacent to the distal end of the catheter body for disrupting occlusions (see Fig. 15). 
More advanced ultrasound catheters feature catheter bodies and ultrasound 
transmission members with increased distal flexibility, guidewire tubes allowing 
contact between the guidewire and the ultrasound transmission member, distal heads 
with improved guidewire lumens, and torquable proximal housings to ensure 
enhanced disruption of vascular occlusions [61]. 
 
Fig. 15. Steerable ultrasound catheter, where 1 is the guidewire; 2 is the wall of the 
guidewire; 3 is the waveguide; 4 is the hall for the waveguide [61]. 
Apparatus and method for an ultrasonic medical device operating in torsional 
and transverse modes. This invention offers an apparatus and a method for an 
ultrasonic medical device intended to operate in torsional and transverse modes. An 
ultrasonic medical device has an ultrasonic probe which is placed in communication 
with a biological material. Once the ultrasonic energy source has been activated, it 
produces an electrical signal that drives a transducer to produce a torsional vibration 
of the ultrasonic probe [62]. As a result, the torsional vibration produces a component 
of force in a transverse direction relative to the longitudinal axis of the ultrasonic 
probe, thereby exciting transverse vibration along the longitudinal axis. This vibration 
causes the ultrasonic probe to undergo both torsional vibration and transverse 
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vibration, both of which concurrently cause cavitation in a medium surrounding the 
ultrasonic probe to ablate the biological material (Fig. 16). 
 
Fig. 16. Apparatus and method for an ultrasonic medical device operating in torsional and 
transverse modes, where 1 is the ultrasound waveguide; 2 are torsional vibrations; 3 are 
transverse vibrations [62]. 
Ultrasonic catheter for disrupting vascular occlusions. Ultrasonic catheters 
provide better disruption of vascular occlusions. Usually, an ultrasonic catheter 
consists of the elongated catheter body with one or more lumens. An ultrasonic 
transmission member or a wire extends through the catheter body lumen and, in many 
embodiments, a guidewire tube also extends through the same lumen [63]. A distal 
head is fixed to or otherwise mechanically coupled with the distal end of the ultrasonic 
transmission member or the wire and is positioned adjacent to the distal end of the 
catheter body. Although the distal end of the catheter body overlaps the distal head, 
the distal head is not directly fixed to the distal end of the catheter body (see Fig. 17). 
Thus when ultrasonic energy is applied through the ultrasonic transmission member, 
the distal tip is capable of moving freely with respect to the distal end of the catheter 
body. Such a freely floating distal head enables the ultrasonic catheter to remove 
calcific occlusions more efficiently. Moreover, it increases the life of the ultrasonic 
transmission member and the catheter. 
 
Fig. 17. Ultrasound catheter for disrupting blood vessel obstructions, where 1 is the 
ultrasound transmissiom nember; 2 is the low friction coating or jacket  [63]. 
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Ultrasonic catheter and methods for making and usage thereof. Ultrasound 
catheter devices and their operation methods provide enhanced disruption of blood 
vessel obstructions. Generally, ultrasound catheters include an elongated flexible 
catheter body with one or more lumens, an ultrasonic transmission member extending 
longitudinally through the catheter body lumen and, in some embodiments, a 
guidewire tube extending through the lumen (Fig. 18). A distal head for disrupting 
occlusions is coupled with the distal end of the ultrasonic transmission member and 
is positioned adjacent to the distal end of the catheter body. Some embodiments 
include more advanced features such as a bend in the catheter body for enhancing the 
positioning and/or for the advancement of the catheter [64]. 
 
Fig. 18. Ultrasound catheter and methods of its functioning and use, where 1 is the mandrel 
on which the catheter body is formed; 2 is the bent catheter body; 3 is the stopper member  
[64]. 
Ultrasonic catheter with a protective feature against breakage. An ultrasound 
catheter is comprised of an elongated flexible catheter body having a lumen extending 
longitudinally therethrough, and an ultrasonic transmission member extending 
longitudinally through the lumen of the catheter body [65]. A proximal end of the 
ultrasonic transmission member is coupled to a separate ultrasound generating device. 
Its distal end terminates at the distal end of the catheter body. At least some portion 
of the distal end of the ultrasonic transmission member extends outside the lumen of 
the catheter body and beyond the distal end of the catheter body. The ultrasonic 
transmission member is directly attached to the catheter body via an attachment device 
(see Fig. 19).  
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Fig. 19. Ultrasound catheter featuring a protective feature against breakage, where 1 is the 
catheter; 2 is the waveguide wire; 3 is the distal end of the waveguide [65]. 
Vibrational catheter devices and their applications. This is a vibrational 
catheter designed for disrupting occlusions in lumens such as blood vessels. It 
includes an elongated flexible catheter body that has a proximal end, a distal end and 
at least one lumen extending longitudinally through it. There is a vibrating 
transmission member that extends longitudinally through the lumen of the catheter 
body. It has a proximal end and a distal end, and a transition connector attached to the 
proximal end of the vibrating transmission member for coupling the transmission 
member with a vibrational energy source [66]. The transition connector includes a 
bore into which the proximal end of the vibrating transmission member extends (Fig. 
20). The proximal end of the vibrating transmission member is attached within the 
bore of the transition connector with variable attachment forces in order for the 
transition connector to exert a minimum amount of attachment force on the attached 
distal-most portion of the vibrating transmission member housed within the bore. 
 
Fig. 20. Vibrational catheter devices and methods, where 1 is the intake; 2 is the waveguide 
wire; 3 is the transition connector [66]. 
Ultrasound catheter with an improved distal end. This ultrasound catheter is 
comprised of an elongate flexible catheter body featuring a lumen that extends 
longitudinally through it. There is also an ultrasound transmission member extending 
longitudinally through the lumen of the catheter body. The ultrasound transmission 
member has a proximal end that is coupled to a separate ultrasound generating device. 
Its distal tip is attached to the distal end of the ultrasound transmission member which 
is located at the distal end of the catheter body [67]. The distal tip has at least one-
dimensional step. The ultrasound transmission member is directly attached to the 
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catheter body and/or to a guidewire tube, either directly or via an attachment device 
(Fig. 21). An additional radiopaque marker is positioned on the distal end of the 
catheter. 
 
Fig. 21. Ultrasound catheter having an improved distal end; 1 is the catheter; 2 is the 
ultrasound transmission agent; 3 is the distal end of the ultrasound transmission member 
[67]. 
Ultrasonic catheter for disrupting vascular occlusions. Ultrasonic catheters 
provide better disruption of vascular occlusions. Usually, an ultrasonic catheter 
consists of the elongated catheter body with one or more lumens. An ultrasonic 
transmission member or a wire extends through the catheter body lumen and, in many 
embodiments, a guide wire tube also extends through the same lumen [68]. A distal 
head is fixed to or otherwise mechanically coupled with the distal end of the ultrasonic 
transmission member or the wire and is positioned adjacent to the distal end of the 
catheter body. Although the distal end of the catheter body overlaps the distal head, 
the distal head is not directly fixed to the distal end of the catheter body (Fig. 22). 
Thus the distal tip may move freely relative to the distal end of the catheter body when 
ultrasonic energy is being applied through the ultrasonic transmission member. Such 
a freely floating distal head enhances the efficiency of an ultrasonic catheter thus 
enabling it to remove calcific occlusions and increasing the life of the ultrasonic 
transmission member and the catheter itself. 
 
Fig. 22. Ultrasound catheter for disrupting blood vessel obstructions, where 1 is the catheter; 
2 is the ultrasound transmission member; 3 is the guide wire lumen [68]. 
Treatment of vascular occlusions using ultrasonic energy and microbubbles. 
One method of treating vascular occlusions within a patient’s vasculature requires 
positioning an ultrasonic catheter at the treatment site (Fig. 23). Further, during the 
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first treatment phase, the method requires to deliver the catheter’s microbubble-
therapeutic compound to the vascular occlusion [69]. 
 
Fig. 23. Treatment of vascular occlusions while using ultrasonic energy and microbubbles, 
where 1 is the energy delivery section ; 2 is the cable; 3 is the inner core of the waveguide 
[69]. 
Method and Apparatus for Ablative Recanalization of Occluded Vasculature. 
In this particular case, a technique is offered for treating blood vessel occlusions, 
including chronic total occlusions (CTO) of the coronary arteries, with the capability 
to remove tissue material. This method is based on remotely actuated motion of an 
interventional RF-capable ablation device to the occlusion and controlled application 
of ablative RF energy [70]. The combined use of remote navigation-based precision 
control of the distal end of the device and the application of ablative energy enables 
the device to traverse elongated lesions and CTOs, as well as calcified lesions and 
CTOs, blockages and CTOs located at vessel branches, and in general allows the 
removal of the tissue material at the selected site of the tissue (Fig. 24). 
 
Fig. 24. Method and apparatus for ablative recanalization of blocked vasculature, where  1 is 
the waveguide; 2 is a blood vessel; 3 is a blood vessel occlusion [70]. 
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Ultrasound waveguide wire for internal clearing of blood vessels. The 
domain of medicine can benefit from this particular invention as it may be applied for 
cleaning vascular walls from the inside. 
With the aim to increase the efficiency and reliability of blood vessel 
cleaning, an ultrasound wave guide wire is used consisting of a metal wire with a 
tapered flexible cross-section (denoted 1) and its operational part (denoted 2), which 
is attached to the distal end of the catheter. The wire is made of a flexible material. 
The distal part of the wire equally makes the operational part (denoted 2) of a spiral 
shape. Its length is at least ¼ λ, where λ is the wave length of the waveguide wire 
ultrasonic longitudinal vibration. The strand step is no more than 0.5 mm. The helical 
end makes a closed ring-shaped circuit as the ending of a spiral’s last strand is 
connected to the beginning of the last strand (denoted 3). Then, the ending of the 
spiral’s last strand is connected through the entire internal length of the spiral to the 
beginning of the spiral’s first strand by the general component (denoted 4) and the 
housing. Thereby the spiral runs in the shape of a tube, whose walls are folded in 
zigzag. The ending of the last strand of such a zigzag is attached to the beginning of 
the last zigzag strand [71]. Once the flexible guidewire (denoted 5) has advanced 
through the internal cavity of the operational part and the operational part has 
advanced through arterial vessels, it is capable of flexing into different directions (see 
Fig. 25). Furthermore, all the connections of the spiral part are produced by way of 
mechanical twisting and/or spot welding. 
 
Fig. 25. Ultrasound wave guide wire for internal blood vessel cleaning, where 1 is the 
waveguide; 2 is the spiral end of the waveguide [71]. 
Despite a huge variety of invasive devices for cardiovascular recanalization, 
there is no vascular clearing device with the following capabilities: a) ability to 
operate in an invasive mode, as it is considered to be the most effective one; b) ability 
to deliver the required volume of drugs to the selected site of clearing; c) ability to 
instantly suck away the scurf of the blood clot being dissipated, at the same time; d) 
ability to ensure adequate  advancement of the device forward (along the z axis). 
2.7. Industrial Devices for the Intravascular Thrombus Decomposition 
Endo Wave Infusion Catheter System The EndoWave Infusion Catheter System 
is designed for catheter-directed thrombolysis by accelerating the fibrinolytic process 
via ultrasound (see Fig. 26). The device combines a multiple side-hole drug infusion 
catheter with a guidewire-exchangeable ultrasound core for infusing therapeutic 
substances and delivering high frequency, low power ultrasound energy 
simultaneously [72]. EKOS Endo Wave Infusion Catheter System is different in a way 
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that it has three ultrasound transducers along the core wire. It combines a targeted 
drug delivery cathether with high frequency low-power US energy. Drugs are 
delivered through the catheter, not through the core wires. US accelerated CDT 
(Catheter-directed-thrombolysis) is used to make the blood vessel treatment procedure 
safe and instant; it also eliminates potential side effects. There is very little clinical 
data available concerning the feasiblity, safety and efficiency of additional US-
accelereated CDT, but the current results are very promising [73]. The success rate of 
real-life operations varies between 61% and 85% [74] 
 
 
Fig. 26. Endo Wave Infusion Catheter System (EKOS Corporation) [72]. 
CLEANERXT Rotational Thrombectomy System. This system was presented at 
CIRSE 2016 in Barcelona, Spain (see Fig. 27). It is fitted with dual power cells that 
increase the run time and duration while maintaining the torque through tortuosity. 
The system also involves an improved drive shaft design which further increases the 
efficiency of the power transmission and torque. The device has an FDA clearance. It 
is comprised of a small ‘spiral/helical’ rotating device that extends from the end of 
the guiding catheter. Suction can then be applied manually from a syringe to the side 
port of the catheter aspirating the thrombus. The device has a rather soft end enabling 
it to be used as a guidewire to advance the device. The ‘sinusoidal wire’ is supposed 
to macerate the clot without making any damage to the blood vessel wall. However, 
during device rotation, the vessel wall can be contacted in even large veins and 
aneurysmal sections of dialysis fistulae. The motor and the power supply unit are fitted 
inside the handle of the device. This device is available in the following two versions: 
6F (9 mm sinusoid) and 7F (15 mm sinusoid), and it comes in 65 cm and 135 cm 
lengths. These devices are serious competitors for Angiojet. Although they are by far 
less expensive, their effectiveness is questionable as no trials are available that would 
have attempted to compare them. Thus, so far, the choice among them depends mainly 
on the operator skills and personal preferences [75]. 
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Fig. 27. CLEANERXT Rotational Thrombectomy System (Argon Medical Devices) [75]. 
The AngioJet Ultra Thrombectomy System (see Fig. 28) represents a mechanical 
thrombectomy device for PCI patients suffering from large thrombus burden. 
Moreover, this is the ONLY mechanical thrombectomy device approved by FDA for 
the removal of the thrombus in coronary arteries (see Fig. 29). The system is used to 
mechanically restore the blood flow in patients with thrombosed big arteries (more 
than 6 mm in diameter) [76].  AngioJet™ Ultra allows focused and directional 
thrombectomy for stronger thrombus removal capabilities. The catheter is 2.67 mm in 
width and 105 mm in length. The rotation of the inflow window location at the end of 
the catheter is directed with a torquable cylindrical component at the outside part of 
the catheter. AngioJet™ Ultra has a clear shortcoming in not being able to operate 
only in soft-type blood clot environment (no US is used to ease an opening of a 
hardened plaque) and is limited becaue of the fixed dimensions of the catheter. 
  
Fig. 28. Coronary Thrombectomy System (AngioJet™ Ultra) [76]. 
 
Fig. 29. A thrombus is drawn into the catheter where it is fragmented by the jets and 
evacuated from the body [76]. 
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The Trellis Peripheral Infusion System [77] involves an isolated thrombolysis 
catheter fitted with two occluding balloons, drug infusion holes between the balloons 
and mechanical drug dispersion capabilities. As announced by the manufacturer, such 
a combination of the system’s features enables medical practitioners to provide 
focused treatment of thrombus within a particular vessel (Fig. 30). 
 
Fig. 30. The Trellis Peripheral Infusion System (Covidien) [77].  
The Trellis Peripheral Infusion System is unique because of the two-occluding 
balloon system. After the waveguide goes through the damaged part of the blood 
vessel, two ballons – one at the end of the blood clot and the second one at the 
beginning – inflate. It stops the blood flow and isolates the abolished blood clot, so it 
does not go further through the blood vessel system. After the waveguide has been 
sunk through the damaged part of the blood vessel and the balloons have been inflated, 
the waveguide starts to vibrate thus destroying the scurf. The system does not provide 
an adequate displacement of the waveguide in the frontal direction.  
2.8.  Computational Modeling of Commercial Devices Intended for Clearing 
Blood Vessels  
The delivery of high-power ultrasonic energy via small diameter wire 
waveguides represents an innovative alternative therapy suitable for the treatment of 
chronic complete occlusion of arteries. This type of energy is viable in a form of 
mechanical vibration at the distal tip of the waveguide with the amplitudes of vibration 
up to 60 µm and at frequencies of 20–50 kHz [78]. According to various reports, direct 
mechanical ablation, cavitation, pressure components and acoustic streaming result in 
the disruption of the affected tissue. It should also be noted that mechanical ablation 
was only evident in those cases when the cavitation threshold was exceeded. 
Prediction of the pressure profile generated by the distal tip of the wire waveguide 
was required for 140 elements per wavelength (EPW). 
A significant role appears to be played by the acoustic pressures developed at 
the waveguide-fluid/tissue interface. As some authors observed, plaque ablation was 
only evident above the cavitation threshold [79].  
Due to the significance of the pressure amplitude at the waveguide distal tip, 
the subsequent cavitation, and the pressures generated in the surrounding fluids and 
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tissues, a vast number of researchers became involved in studying this phenomenon. 
Some analytical solutions of simplified geometries and conditions were offered, and 
one of them is a solution involving a pulsating sphere within a fluid and a more 
representative oscillating sphere within a fluid. Equation 1.3 shows the Morse solution 
[80] for the pressure field near an oscillating sphere in a fluid. Although this linear 
solution is limited to a simple geometry, it has been suggested by Nyborg [81] as a 
useful approximation for the prediction of pressure amplitudes and the subsequent 
cavitation associated with the frequencies and conditions encountered in the use of 
ultrasound angioplasty. 
2
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where: Pmax = Pressure amplitude at a location in the fluid, a function of θ and 
r;  d = amplitude of the vibration of the sphere;  f = frequency of the vibration of the 
sphere; R = radius of the sphere; ρ = fluid density; r = radial distance from the centre 
of the sphere; θ = the angle between the direction of oscillation and the radius vector 
With regard to medical applications, high power ultrasound basically represents 
a non-linear propagation of sound waves above approximately 20 kHz. It is derived 
from the nonlinear pressure-density relationship, and the variance in the speed of 
sound with the pressure amplitude during the compression/rarefaction cycle, and with 
higher frequencies and greater intensities, a more significant effect is observed. 
For the purpose of solving the finite element acoustic fluid-structure interaction 
models, the NavierStokes equations of the fluid momentum and the flow continuity 
equation must be taken into consideration along with the structural dynamics 
equation. Assuming linear wave propagation for an incompressible fluid with no mean 
flow, neglecting shear stresses and with a uniform mean density and pressure 
throughout the fluid, the lossless acoustic wave equation can be written as follows 
[78]: 
2
2
2 2
1
0P
c t

 

       (1.4) 
Where 
k
c

  and: k is the bulk modulus of fluid. 
The equation governing the acoustic wave propagation given in Equation 1.4 
can be discretized by taking into account the coupling of acoustic pressure and the 
structural motion present at the fluid-structure interface. 
Fluid: [ ]( ) [ ]( ) [ ] ( ) 0
T
F FM P K P R u       (1.5) 
Structural: [ ]( ) [ ]( ) [ ]( ) ( )S S SM u K u R P F      (1.6) 
Where ( )P  is the 2nd derivative of the nodal pressure vector; ( )P  is the nodal 
pressure vector; ( )u is the 2nd derivative of the nodal displacement vector;  ( )u  is the 
nodal displacement vector [MF] is the Fluid mass matrix; [KF] is the fluid stiffness 
  
 
38 
 
matrix; MS] is the Fluid mass matrix; [KS] is the Structure stiffness matrix; [R] is the 
coupling matrix that represents the effective surface area associated with each node 
on the fluid structure interface; ( )SF  is the fluid pressure load vector 
Further, Equations 1.5 and 1.6 can be combined into a single relationship 
describing the load quantities at all locations in the fluid and structure as shown below 
in Equation 1.7. 
Combined: 
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  (1.7) 
Finite element models applied for ultrasound angioplasty to date have mainly 
focused on modeling the way how the wire waveguide transmits the ultrasonic waves 
to the distal tip. Meanwhile, Gavin et al. [82] opted to perform a modal and harmonic 
analysis in order to determine the resonant characteristics, damping and stresses of the 
wire waveguide. The analysis of mesh density revealed that having an adequate mesh 
density is of huge importance in order to make it possible to resolve the wave structure 
accurately. These authors also undertook the modeling of the effect that the presence 
of fluid had on the resonant response of waveguides. It led to the conclusion that the 
effect was negligible due to the low forces encountered at the distal tip. However, the 
hydrodynamic effects, such as the drag on the distal tip, appeared to be capable of 
playing a more critical role. 
From the theoretical point of view, the process of making a computational 
model is comprised of the following steps:  
1) Model verification that involves analysis of mesh density;  
2) Analysis of an acoustic pressure field versus waveguide parameters;  
3) Validation of the model developed: an in vivo model in a peripheral artery. 
The 3-step FEM methodology was used in the following Chapters 2.3 and 2.4. 
2.9. Formulation of Objectives and Tasks  
According to mortality statistics, cardiovascular disease (CVD) remains the 
most common cause of death in Europe, currently accounting for 45 percent of the 
total deaths, to be more precise, 49 percent of deaths among women and 40 percent 
among men. Each year, more than 4 million people die from CVD in Europe with 1.4 
million of these deaths before the age of 75 years. 
According to the findings of various studies, the burden of CVD mortality 
features huge inequalities across Europe and a significant variation in mortality rates 
from these diseases. On average, EU member countries suffer a lesser burden in terms 
of CVD mortality, whereas the lowest burden on the average is borne by EU-15 
countries (the ones that have been members of the EU the longest). Interestingly, the 
12 countries where the burden in terms of mortality from CVD decreased 
significantly, resulting in the number of deaths from CVD being less than that from 
cancer in men, along with the 2 countries where the same is true for women, are all 
located in Western Europe [83]. 
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Endovascular intervention is the most rapidly growing domain of vascular 
medicine. Peripheral vascular interventions have been developed in pursuit of several 
objectives, some of them being as follows: to avoid the need for general or epidural 
anaesthesia, to eliminate the risks related to conventional surgical procedures, to 
minimize discomfort to the patients, to reduce the recovery times, and to lower the 
cost of treatment [84]. 
One of the endovascular interventional techniques covers ultrasound 
enhanced catheter-directed thrombolysis. Generally, it involves high-frequency low-
energy ultrasonic waves, concurrently with the infusion of thrombolytic drugs with 
the general aim of accelerating plasmin-mediated thrombolysis. It is designed to 
reduce the treatment duration, the dose of the infused thrombolytic drug, and 
thrombolysis-related complications when compared to catheter-directed thrombolysis 
alone [85]. 
A comprehensive literature review revealed a need for an innovative ultrasonic 
vascular clearing device with the following capabilities: a) operating in an invasive 
mode, as it is considered to be the most effective one; b) delivering the required 
volume of drugs to the selected site of clearing; c) instantly sucking away the scurf of 
the blood clot being dissipated at the same time; d) ensuring adequate advancement 
of the device forward (along the z axis). 
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3. DESIGN AND MODELING OF THE WAVEGUIDE 
During the process of the research, two different ultrasonic devices were 
designed for vascular clearing. They are intended to operate in the same frequency 
range of (15–30 kHz) and to perform a similar primary function (vascular 
recanalization). However, they are radically different in their structure and principle 
of operation. The structures of these two waveguides are presented in detail below. 
Since the second invention, detailed in Chapter 2.2, is more functional, easier to be 
produced, and in fact represents an improved version of the first one, the ‘Ultrasonic 
device for internal vascular clearing’ discussed in Chapter 2.1 was not experimentally 
investigated. 
In both cases under consideration, the waveguide system is comprised of the 
guiding catheter, a thinner soft wire (to prevent perforation of a blood vessel) fitted 
with the second catheter, also made of a soft material which is used to simultaneously 
pull through the first catheter while introducing the elongated metal waveguide into 
the blood vessel. 
In the further research, discussed in detail in Chapters 3 and 4, the waveguide 
(an innovative device being designed) is investigated without taking into 
consideration the guiding catheter and the second catheter, which, while being larger, 
mainly performs a protective function. 
3.1.  Design of Ultrasonic Device for Internal Vascular Clearing 
3.1.1. Description of the Device 
The invention under consideration here is attributed to the field of medicine as 
it can be applied for the pharmaceutical clearing of blood vessel inner walls as well 
as the suction of the plaque deposited on the surface of these walls. 
The ultrasonic vascular clearing system is comprised of the source of ultrasound 
made of a high frequency ultrasound generator and a piezo transducer, a concentrator 
of mechanical vibrations which is connected in series, a metal wire waveguide with 
its free end being in a shape of a spiral and which is made of a solid and the same 
highly elastic substance, for instance, stainless steel, nickel, titanium or alloys thereof. 
The ultrasonic micropump-dispenser intended for supplying and dispensing 
liquids is comprised of a cylindrical body fitted with the conical spiral member inside 
of it, and the generator inducing vibrations, i.e., a piezoceramic ring is placed on the 
cylindrical body. The cylindrical body is filled with the relevant liquid. 
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Fig. 31. Ultrasonic volumetric dispenser: 1) is the waveguide; 2) is the operational part; 3) 
are the spheres; 4) is the spring; 5) is the ultrasound generator; 6) are spiral threads; 7) is 
confined space. 
The closest possible analogue is presented in European patent application No. 
08478001.4: the ultrasonic device for internal vascular clearing comprised of the 
specifically shaped waveguide with its free end being twisted into the spiral. The 
waveguide is excited from the generator of high frequency vibrations. 
The above mentioned device can be charged with a liquid (drugs) to be 
dispensed from the end of the waveguide of a spiral shape. However, the liquid can 
only be charged if it is in the form of a frozen capsule or powder (drugs) mixed with 
viscous grease that, under the influence of the vibrations induced from the ultrasonic 
generator and transmitted through the waveguide to the spiral, is/are spread at the 
localized site of the blood vessel. The generated scurf is sucked away into the catheter 
through a special exterior suction device. 
The ultrasonic device of the innovative design for the internal vascular clearing 
covered by this invention offers a solution of the shortcomings characteristic to the 
devices discussed above. It also boosts the efficiency of the vascular clearing and 
expands the functional capabilities of an ultrasonic device (including the local dosing 
of drugs and sucking away the scurf). 
The aim of the invention was to increase in efficiency the vascular clearing 
while expanding its functional capabilities (the local dosing of drugs and sucking 
away the scurf) of the ultrasonic device for the internal vascular clearing, which is 
achieved by making the clearing device’s waveguide out of the wire of a variable 
diameter and involving an operational part of a spiral shape which is clamped between 
two spheres by using a spring. This results in a confined cavity which may be charged 
with drug delivery nanosystems, for instance, nanoparticles, nanospheres, 
nanocapsules, and hydrogels. Sucking away the generated scurf into the catheter 
happens in a confined space between the strands of the spiral by means of creating 
vacuum and by inducing deformations of the running wave of the opposite direction 
within the waveguide. 
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3.1.2. Structural Layout of the Device  
Fig. 32 shows the vascular clearing device, comprised of the ultrasonic 
waveguide (1) having the operational part of a spiral shape (2) which is confined by 
spheres on its both sides (3’, 3”) attached to each other by the spring (4), inside of 
which, drug delivery nanosystems are to be placed (not shown in the figure), such as 
nanoparticles, nanospheres, nanocapsules, and hydrogels. The above-mentioned 
waveguide is attached to the ultrasonic vibration generator (5) through a thread 
connection.  
 
Fig 32. A schematic view of operation of the ultrasonic volumetric dispenser, where 1) is the 
waveguide; 2) is the operational part; 3) are spheres; 4) is the spring; 5) is the ultrasound 
generator; 6) is the cavitational stream; 7) are spiral threads; 8) is confined space. 
High frequency mechanical vibrations coming from ultrasound generator (4) 
are transmitted to waveguide (1) where they continue to propagate over its entire 
length to the operational part of a spiral shape (2). Due to its specific structure, the 
operational part of the waveguide (2) allows placing a particular limited amount of 
drugs inside of it delivered in a form of nanoparticles (drug carrier nanosystems), 
which in turn enables feeding the drug to the selected site (the point of lesion).  
When the internal vascular clearing device is in operation, the mechanical 
motion of its operational part (2), the increased temperature and the hydrodynamic 
processes occurring in the blood speed up the distribution of drugs in a form of 
nanoparticles in the operational field (at the site of the lesion). Nanoparticles (which 
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are spread in the fluid) are exposed to the concentrated energy flowing through the 
waveguide (1) and its operational spiral part (2) with spheres (3’, 3”) resulting in 
cavitation processes within the blood vessel. The cavitation process is distributed over 
the entire length of the operational part (2) in the radial direction (6). In the course of 
the cavitation process, microbubbles are formed in the fluid (i.e., blood), and the 
microenergy released during their rupture tends to disrupt the sediments built up on 
the interior walls of the blood vessels thus destroying (removing) blockage from the 
blood vessel. By inducing bending deformations opposite in direction within the 
waveguide (1) and simultaneously within the operational part (2), sucking away the 
generated scurf into the catheter takes place (not shown in the figure) through the 
vacuum created in the confined space (8) available between the strands of the spiral 
(6) and the spheres (3’, 3”). 
In comparison to its closest possible analogue, this ultrasonic device of the 
innovative design for internal vascular clearing with the included drug delivery 
nanosystems helps lowering the cavitational threshold (the amount of the energy 
required to induce cavitation), breaks and dissolves the thrombus present inside of the 
vessel, promotes tissue regeneration processes, minimizes the risk of drug overdosing 
and enables eliminating the scurf generated inside of the blood vessel which in turn 
increases the reliability and efficiency of the vascular clearing. 
3.1.3. Novelty of the Device 
The ultrasonic device for internal vascular clearing offered by this invention is 
different from its predecessors as follows: 
1. The free ending of the ultrasonic device for internal vascular clearing is 
twisted into a spiral thus making an internal cavity inside of the operational part of the 
waveguide additionally limited by two spheres that are interconnected with a spring 
while creating a confined space limited by the strands twisting in a shape of a spiral 
and by two spheres. The spiral end of the ultrasonic device can be used as a drug 
transporter. However, it is necessary to freeze or put into the soluble membrane before 
transporting drugs the required place of the body. 
2. This ultrasonic device for internal vascular clearing is distinguished by the 
vacuum created during its operation in the closed cavity of the operational part of the 
waveguide.  
3.1.4. Technological Challenges  
The ultrasound catheter under consideration contains a metal wire probe with a 
free ending leading to a risk of the spiral part’s fracture under particular frequencies 
of spiral vibrations. 
The volume of the drugs delivered through a catheter is limited due to its 
structural features, i.e., the size of the frozen capsule to be inserted is determined by 
the cavity available between the strands of the spiral that link two spheres in the 
operational part of the waveguide.  
The device described herein possesses no capability to precisely divert and 
target the dispensed-sucked liquid to the localized site of the blood vessel to be treated 
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through the catheter as the entire catheter has to be filled with the fluid, and the source 
of vibrations is located outside the device, which makes it less efficient than desired. 
Although the ultrasonic volumetric dispenser is sound theoretically, due to clear 
technological challenges described above, the decision to continue developing an 
ultrasound waveguide was made. Therefore, the design of the tube-shaped ultrasound 
waveguide described in Chapter 2.2. was created. 
3.2. Design of the Tube-Shaped Ultrasound Waveguide 
3.2.1. Description of the Device 
The results described/presented in this chapter have been published in the 
following article: Kargaudas, V., Bubulis, A., Navickas, J., Vitkus, L., Venslauskas, 
M. Theoretical and Experimental Investigation of Tube-Shaped Waveguide Wire. 
Journal of Measurements in Engineering 5, 2017, 257-265.  
The tube-shaped ultrasound waveguide wire with orifices at its operational end 
was offered as the alternative to some currently patented interventional thrombosis 
treatment solutions. The principal scheme of an innovative waveguide is presented 
below in Figures 34 and 35. 
  
 
 
Fig. 33. Ultrasonic vascular cleaning device (cross-section). 
 
Fig. 34. Ultrasonic blood vessels cleaning system, where: 1) is the tube-shaped waveguide; 
2) is the waveguide hole; 3) is the fixing screw; 4) is the lug; 5) is the intake; 6) is the 
concentrator; 7) is the transducer. 
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The waveguide wire of 260 mm in length and 1.5 mm in diameter is considered 
to be an interventional medical device. It can be used for cleaning the inner walls of 
arteries. It can also be used as a tool to break down and destroy the thrombus and 
simultaneously suck out the scurf of the blood clot being dissipated. 
Adequate feed of the drugs to the damaged site of the blood vessel is secured 
by the unique design of the wire. The lug that enables the device to get attached to the 
concentrator is separated from the tube intended for drug infusion. Fig. 34 shows its 
construction in detail. The diameter of the intake is 1.1 mm. 
The waveguide wire of such a structure allows impacting the occlusion not only 
mechanically but also by the flow of physiological fluid infused through the intake 
(denoted 5 in Fig. 34). 
To ensure the efficient delivery of a sufficient quantity of drugs to the required 
site of the artery to be treated, a tube-shaped waveguide wire was selected. The 
orifices drilled at the end of it act both as intake and suction holes, if necessary.  
 
Fig. 35. The tip of the waveguide: 1) is the blood vessel wall; 2) is the occlusive derivative; 
3) is the waveguide; 4) is the wall of the waveguide. 
The dimensions of the waveguide were selected based on the standard diameter 
of arteries in lower human limbs. To ensure that the device is capable of operating 
even at the level of popliteal arteries, the diameter of 1.5 mm was specifically chosen 
for the waveguide. The selection of the other dimensions, as well as the length 
optimization of the innovative design system under consideration, are disclosed in the 
upcoming European patent application “Tube-Shaped Ultrasound Wave Guide Wire 
for Internal Blood Vessels Cleaning”. 
As arteries can be totally (meaning that the blood circulation is completely 
blocked) or partially occluded (meaning that a blood clot might be adhered to the wall 
of the blood vessel), waveguide holes can be positioned in the following two 
directions – frontal (for totally occluded arteries) and transverse (for partially 
occluded arteries). As an alternative, holes may only be positioned at the front or only 
on the side of the waveguide; however, in this case, the waveguide under 
consideration would only be useful for very specific situations. 
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3.2.2. Structural Layout of the Device 
The vascular clearing device shown in Fig. 34 involves a tube-shaped 
waveguide (1) with the holes drilled at its tip (2), a trough (3) and an open aperture 
(5) for the infusion of drugs and physiological saline solution to the required site of 
the blood vessel under treatment, and a metal screw (3) used to attach the waveguide 
to the concentrator (6) through a specific lug (5). The system is excited by a high-
frequency vibration generator. 
During the operation of the vascular clearing device, the mechanical work 
accomplished by its operational part (1) not only destroys harmful formulations 
present in its vicinity inside the blood vessel by means of the induced cavitation 
process but also effectively distributes drugs being fed to the site of lesion. The tube-
shaped part (1) of the waveguide while vibrating in its radial and frontal directions 
causes the cavitation process in blood. 
The process of cavitation causes microbubbles to form in the fluid (i.e., in 
blood), and the microenergy released during the rupture of these bubbles disrupts the 
sediments built up on the interior walls of the blood vessels thus destroying 
(removing) blockage from the blood vessel. 
To increase the efficiency of the interior vascular clearing while simultaneously 
expanding the functional capabilities of the ultrasonic device for internal vascular 
clearing, a steel tube (1) was used as one of the parts comprising the waveguide with 
the holes drilled at its tip (2). The open orifice (4) at the tip of the tube-shaped part of 
the waveguide enables feeding an unlimited volume of drugs through the trough to 
the damaged site of the blood vessel under treatment, and at the same time allows 
sucking away scurf of broken harmful formulations generated during the operation of 
the clearing system. 
Smooth feeding of drugs is ensured due to the unique structural solution built-
in in the waveguide – its separate part that is present at the concentrator which is not 
used for the delivery of drugs to the damaged site of the blood vessel – is attached to 
it with the metal screw (3). 
In comparison to its closest possible analogue, this ultrasonic device of the 
innovative design for internal vascular clearing with the included drug feeding system 
breaks, dissolves and removes thrombus present inside of the vessel, promotes tissue 
regeneration processes, ensures the delivery of any required amount of drugs, and, if 
necessary, is capable of operating in a freshly supplied blood substitute (physiological 
saline) instead of blood, which in turn significantly increases the reliability and 
efficiency of vascular clearing. 
3.2.3. Novelty of the Device 
1. The ultrasonic device for internal vascular clearing comprised of the 
waveguide of a specific shape with holes drilled at its tip is distinguished by the 
hollowed operational part which also has an orifice for feeding the required amount 
of the fluid. 
  
 
47 
 
2. The ultrasonic device for internal vascular clearing makes it possible to 
deliver an unlimited volume of drugs to the selected site of a damaged blood vessel 
through the open part of the waveguide. 
3. High frequency vibrations transmitted by this ultrasonic device for internal 
vascular clearing bypass the site used to feed the drugs or physiological saline. 
Vibrations are transmitted from the concentrator to the required site of the blood 
vessel treated through a separate fixation member including the screw. 
4. The ultrasonic device for internal vascular clearing under consideration here 
offers the possibility of executing the cavitation process (breaking and disrupting 
adjacent tissues and causing high temperatures) in a specific fluid fed from the outside 
instead of the patient’s blood. 
 
3.2.4. Technological Challenges 
The use (or the reliability, to be more precise) of the above-discussed invention 
is mainly limited by the relatively complicated structure of its component (4) in Fig. 
34, i.e., the lug. It requires the highly accurate and precise welding of the tube (1) and 
the lug. Otherwise, not only the reliability of the device operation may be impaired 
but the transmission of the high frequency vibrations from the generator to the 
damaged site in the human body might be impeded as well.  
3.3. Computational Modeling of a Waveguide Wire Operating within a Blood 
Filled Blood Vessel 
Simulation of the tube-shaped ultrasonic waveguide wire under consideration 
was accomplished by using the Finite Element Method (FEM). Eigenfrequency 
analysis was performed for the body of waveguide in addition to time-dependent 
simulation for the entire waveguide wire structure. The waveguide wire was modeled 
by using COMSOL Multiphysics – a finite element analysis, solver and simulation 
software package intended for various engineering and physics applications and 
coupled phenomena. Fig. 36 features a geometry and FEM meshing of the model.  
Interface of Solid Mechanics physics was used to model the behavior of the 
waveguide wire. Structural steel with density ρ = 7,850 kg/m3, Young’s modulus 
E = 200e9 Pa, and Poisson’s ration nu = 0.33 were applied to the body of the tube-
shaped ultrasound waveguide wire and its housing. The main equations governing the 
finite element model for the time-dependent study are as follows: 
2
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Here, u denotes the displacement field; t denotes time; ρ is the density of the 
material; σ is the stress tensor; F represents an external volume force; v denotes the 
velocity, ε is the strain value (ε0 is the initial strain, εirei is the inelastic strain), S 
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represents stress (S0 is the initial stress value), C is a tensor product. The ambient 
temperature condition is T = 293.15, and the absolute pressure is PA = 1 atm. 
Understanding the dynamics of a waveguide vibrating in an elastic fluid-filled 
vessel is important for effective applications of ultrasound in invasive blood-vessel 
cleaning systems. Numerical simulations are performed based on a two-dimensional 
(2D) asymmetric finite element model to investigate the influences of both acoustic 
driving parameters (e.g., pressure and frequency) and material properties (the vessel 
size, visco-elastic parameters, and fluid (blood) viscosity) on the dynamic interactions 
in the waveguide-blood-vessel-muscle system. A simplified model is shown in the 
figure below, and the main parameters of the simplified model are described in Table 
1. 
 
Fig. 36. A simplified model of the waveguide operating inside a blood vessel, where M1 is a 
human muscle; M2 is the wall of the blood vessel; M3 is blood; M4 is stainless steel; Point 1 
is the pressure measuring point within 1 mm distance from the tip of the waveguide; Point 2 
is Pressure measuring point 2 within 2.25 mm distance from the side of the waveguide; P1 is 
the pressure inside the blood vessel; P2 is the pressure inside the wall of the blood vessel. 
 
Table 1. Main parameters of the simplified model 
Diameter of the waveguide 1.5 mm 
Artery diameter 6 mm 
Waveguide length 260 mm 
Waveguide fixing point On the right 
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Fig. 37.  Illustration of the geometry and FEM meshing of the simplified waveguide wire and 
the surrounding tissues. 
FEM analysis showed that the surrounding fluid does not have any notable 
impact on the piezo rings-generated high frequency (~22-24 kHz) longitudinal 
vibrations, although it is significant for the modes of transverse vibrations. Fig. 38 
describes the longitudinal displacement of the vibrating waveguide (cylinder) that was 
fastened on the right. 
 
Fig. 38.  Real vibration forms. The green line shows the longitudinal vibrations, the 
blue line represents the transverse vibrations. 
Fig. 39 shows the resonance frequency of the rod for the best longitudinal 
vibrations. The difference between the resonant frequency in a fluid environment 
(water) or air is insignificant. The rod was actuated by the longitudinal 5 μm 
movement of the piezo ring. Analysis showed that the resonant frequency providing 
the best displacement of the tip of the waveguide is 24.970 kHz.  
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Fig. 39. Amplitude-frequency characteristics at the end of the rod. 
 
A transient analysis of the working system (in 24.970 kHz) is shown in Fig. 40. 
Fig 41 is just an enlarged representation of Fig. 40 for clearer understanding of the 
process and describes vibrations after the process becomes stationary (6×10-4 s after 
the piezo rings start to vibrate). The transient analysis also shows at what point of time 
the excitation is the best and what kind of response to the excitation of the stainless-
steel rod placed in a blood-filled blood vessel it actually provides.  
 
Fig. 40. Transient analysis, where the blue curve denotes excitation; the red curve is 
the longitudinal displacement response to the excitation; the green line is the transverse 
vibrations of the response. 
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Fig. 41. Transient analysis (zoomed), where the blue curve is excitation; the red curve 
shows the longitudinal displacement response to the excitation; the green line demonstrates 
the transverse vibrations of the response. 
 
Fig. 42. Pressure at the point in the middle of the thrombus and rod displacement. The 
blue line is the longitudinal displacement of the tip of the rod; the green line is the pressure at 
the centre point of the thrombus 
The green line in Fig. 42 shows the pressure at the tip of the rod and at the point 
of the middle of the thrombus caused by the longitudinal vibration component. The 
pressure at the tip of the road is ±5.05×105 Pa, and the pressure at the middle point of 
the thrombus is ±2.40×105 Pa. 
Further graphs show the results of the analysis of the vibrational period of the 
rod at four different points of time after the vibration process becomes stationary:  
1562 (A) – stretched in frontal direction; 
1573 (B) – at point 0 between being stretched and shrunken; 
1583 (C) – shrunken in the frontal direction; 
1593 (D) – at period point 0. 
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Fig. 43. The particular analyzed time points of the stationary process. The blue curve 
denotes excitation; the green curve shows the displacement response at the tip point of the 
rod. The numbers above the curves show the time point of the process. 
 
As it is shown in Figure 43, the best displacement of the Y component is 
±2.3×10-5 m. Fig. 44 shows displacements of the wall of the blood vessel throughout 
its length at different time points during the time period.  
 
Fig. 44. Transverse displacement of the wall of the blood vessel. The blue curve is at time 
point A (when the rod is stretched in the frontal direction); the green curve is at time point  B 
(at point 0 between being stretched and shrunken); the red curve is at time point C (the rod is 
shrunken in the frontal direction); the electric curve is at time point  D (at point 0). 
Fig. 45 is related with Fig. 38 (the first figure of Chapter 2.4.). The mode of the 
longitudinal vibration is influenced by longitudinal and transverse vibrations. Fig. 46 
shows an enlarged and more detailed view of Fig. 45. 
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Fig. 45. Pressure to the inner wall of the blood vessel. The blue curve is given at time point 
A (when the rod is stretched in the frontal direction); the green curve is at time point  B (at 
point 0 between being stretched and shrunken); the red curve is at time point  C  (the rod is 
shrunken in the frontal direction); the electric curve is at time point  D (at point 0). 
 
Fig. 46. Pressure to the inner wall of the blood vessel (enlarged). The blue curve is given at 
time point A (when the rod is stretched in the frontal direction); the green curve is at time 
point  B (at point 0 between being stretched and shrunken); the red curve is at time point  C 
(the rod is shrunken in the frontal direction); the electric curve is at time point  D (at point 0). 
Analysis shown in Figures 45–46 show that the optimal pressure (±3.5×105 Pa) 
when the ultrasound vascular clearing system is working in the resonant mode 
happens at the tip of the waveguide. Therefore, it generates the best pressure to the 
inner wall of the blood vessel.  
The following graphs show the variations of the pressure fields and the intensity 
of deformations at the previously described time points (A, B, C and D) of the 
vibration period. The lines describe the pressure fields, while the intensity of the 
colors describes the intensity of deformation.   
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Fig. 47. The pressure fields and intensity of deformation at time point A (1), when the rod is 
stretched in the frontal direction.  The left column shows pressure (Pa), while the right 
column shows displacement (mm).  
 
Fig. 48. The pressure fields and intensity of deformation at point B (0). The left column 
shows pressure (Pa), while the right column shows displacement (mm). 
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Fig. 49. The pressure fields and intensity of deformation at time point C, when the rod is 
shrunken in the frontal direction. The left column shows pressure (Pa), while the right 
column shows displacement (mm). 
 
Fig. 50. The pressure fields and intensity of deformation at time point D, when the rod is at 
the end of the vibrational period. The left column shows pressure (Pa), while the right 
column shows displacement (mm). 
Figures 47–50 graphically show blood velocity and acceleration. The size of 
the arrow varies according to the size of the vectorial field. The same four time points 
during the particular period were analyzed. The analysis shows nodes and antinodes 
that appear during the process. The distance between the nodes is about 10 mm. The 
intensity of deformation is the optimal on the first anti-node (at the tip of the 
waveguide) and gets smaller with each node towards the fixed part of the waveguide. 
The best blood vessel wall displacement appears at time point B and is -9.38 ×10-3 
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mm. The best pressure to the inner wall of the blood vessel appears at time points A 
and C and is ±7.85×105 Pa. 
 
Fig. 51. The vectorial acceleration and blood velocity field at time point A. 
 
Fig. 52. The vectorial acceleration and blood velocity field at time point D.  
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Fig. 53. The vectorial acceleration and blood velocity field at time point C. 
 
Fig. 54. The vectorial acceleration and blood velocity field at time point D.  
The FEM modeling showed that an increased pressure field is generated while 
the ultrasound blood vessel cleaning system is working at its resonant frequency. The 
phenomenon of streaming at different flow rates in the direction of the blood flow 
appears as well. The streaming activates the destruction of the thrombus or another 
occlusive derivative inside the blood vessel. 
3.4. Summary of Chapter 2 
The waveguide of 260 mm in length and 1.5 mm in diameter has been 
developed for clearing blood vessels in the human body that is attached to the 
concentrator (a comprising part of the transducer) through a lug of a specific shape by 
using a screw (as the thread connection).  
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The FEM modeling of the simplified waveguide acting in close to real-life 
conditions (in a muscle-surrounded blood vessel filled with blood) showed that the 
best frequency for the greatest amount of frontal and transverse pressure is 24.970 
kHz. While working in such a resonant mode, the best waveguide tip point 
displacement towards the z axis (forward) is 8.3 μm.  
FEM modeling also allowed to determine the nodes and the anti-node dynamics 
through the length of the waveguide. It was determined that the most intensive (i.e., 
providing the optimal pressure and displacement of the surrounding fluids and tissues) 
value appears at the tip of the waveguide. The nodes and the anti-nodes recur each 10 
milimeters and get lower (within their value) with each next anti-node. The analysis 
also showed that the process becomes stationary after 6×10-4 s after the vibrations of 
the rod start. After the process becomes stationary, the pressure of ±5.05×105 Pa 
(positive and negative at different time points of the period) at the tip of the waveguide 
appears. This pressure is transfered through human blood and becomes lower 
(±2.40×105) at the middle point of the thrombus which is distanced from the tip of the 
waveguide at 1 mm. 
Further analysis of the vectorial acceleration and blood velocity fields at 
different points of time of the period showed that the pressure to the inner wall of the 
blood vessel varies around ±6.91×105 Pa depending on the time point of the period. 
Such a number is a bit lower if compared to the best pressure that appears at the tip of 
the waveguide at ±7.86×105 Pa. 
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4. THEORETICAL INVESTIGATION OF THE TUBE-SHAPED 
WAVEGUIDE WIRE 
The results presented in this chapter have been published in the following 
article: Kargaudas, V., Bubulis, A., Navickas, J., Vitkus, L., Venslauskas, M. 
Theoretical and Experimental Investigation of Tube-Shaped Waveguide Wire. 
Journal of Measurements in Engineering 5, 2017, 257–265.  
The mathematical modeling of the waveguide and its interaction with the 
operational environment involved in the device is detailed in Figures 34 and 35. With 
the aim to gain better understanding of hydrodynamic processes, the modeling did not 
take into consideration the fact that the waveguide is normally operating in the second 
tube-catheter which serves to protect the blood vessel against negative notes 
distributed over the entire waveguide at particular steps of its length (experimentally 
determined nodes and antinodes will be covered in Chapter 4 that follows below). For 
the sake of simplicity of the mathematical model, it was also assumed that, when being 
operated, the tip of the waveguide moves in circles instead of ellipses. The working 
regime of the waveguide tip was selected based on the results obtained from the 
mathematical model described in Chapter 2. 
 
Fig. 55. Input data for the task being solved through modeling: 1) is the wall of the blood 
vessel, 2) is the liquid medium (blood), 3) is the tip of the waveguide moving in circles. 
4.1. Sound Waves in Fluids 
Let us assume that the tube moves slidingly in the plane xy , thus displacements 
of any point in directions of axes ,x y  can be defined as follows [86]: 
cos ,
sin .
x
y
b t
b t
 
 
 


       (3.1) 
The velocities of these points will then be as follows: 
sin ,
cos .
x
y
v b t
v b t
 
 



       (3.2) 
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where b  is the amplitude of displacement,   is the angular frequency in rad/s. 
The radial velocity of surface point B is described as follows: 
 cos sin sin .r x yv v v b t            (3.3) 
Taking into account the fact that the tube is being flexed along the z axis, the 
radial component of the velocity is defined as follows: 
 
2
sin cos ,r
z
z
v b t

  

        (3.4) 
where 
z  is the wave length of the tube deflection in the direction of the z axis. 
The liquid surrounding the tube is considered to be of an/the ideal pressure, 
consequently, the vibrations of the fluid are defined through the following differential 
equation: 
2 2 2 2
2 2 2 2 2 2
1 1 1
.
r r r r z c t
    

    
   
    
    (3.5) 
The individual solution to the potential  , , ,r z t    can be proposed to be 
as follows: 
   
2
cos .
i n t
n n
z
z
R r e b
  


       (3.6) 
The incorporation of this into (3.5) results in a differential equation of Bessel 
as follows [86]: 
2 2
2
2 2
1 4
0,n n n
z
n
R R k R
r r



 
      
 
     (3.7) 
where k c  . The velocity of wave propagation in a fluid 
414.7 10 / ,c cm s    with vibration frequency 21.8 ,kHz  thus 
413.7 10 /rad s    and 
10.932 .k cm
  If the wave length equals 
4 5 ,z cm    then 
12 1.26 1.57
z
cm


   resulting in the following: 
2
2 2 2
2
4
0.72 1.59 .
z
k k cm


         (3.8) 
Taking all the above into account makes a differential equation of Bessel (3.7) 
to be rearranged as follows: 
      
(3.9)
 
2
2
2
1
0.n n
n
R R k R
r r
 
     
 
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Two independent solutions to this differential equation represent modified 
functions of Bessel, namely  nI kr  and   ,nK kr  thus solution (3.6) can be proposed 
to be formulated as follows: 
       
2
cos .
i n t
n n n n n
z
z
D iC I kr iK kr e b
  


    
   (3.10) 
where ,n nD C  are constants. The physical meaning is carried by the real part of 
the complex function (3.6): 
     
      
sin
2
cos cos .
n n n n n
n n n n
z
C I kr D K kr n t
z
C K kr D I kr n t b
  

 

     
    
   
(3.11)
 
Differentiation results in real velocities and pressure within the fluid are as 
follows: 
     
     
sin
2
cos cos ,
n
rns n n n n
n n n n
z
v C I kr D K kr n t
r
z
C K kr D I kr n t kb

 

 


       
     
   
(3.12)
 
     
     
cos
2
sin cos .
n
ns n n n n
n n n n
z
p C I kr D K kr n t
t
z
C K kr D I kr n t b



  

   


      
    
  
(3.13)
 
where   is the fluid density. The real velocity and pressure are obtained by 
summing up in the following way: 
1 1
, .rs rns s ns
n n
v v p p
 
 
         (3.14) 
4.2. Sound Waves in a Tissue 
The fluid is assumed to be confined by the tissue in the form of a concentric 
cylinder with the radius of 
1 ,or r  or  representing the radius of the tube. To some 
extent, the simplest way to describe the effect of sound waves propagating within the 
fluid on the tissue is to use the hypothesis proposed by E. Winkler ,w rp k    where 
p  is the pressure on the tissue, 
r  is the radial displacement of the tissue, wk  is the 
constant. Such a law might be applicable in case p  and 
r  are independent of angle 
 , i.e., if the excitation of vibrations is pulsed. When p  and 
r  are dependent on 
, the determination of the coefficient of proportion 
wk  becomes somewhat difficult 
and complicated, and the very assumption hardly reflects the reality. For this reason, 
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it is assumed that the fluid is confined by a limitless tissue into which sound waves 
are transmitted, and they keep propagating further in a similar fashion as in a fluid. 
The computation of dynamics for the tissue is proposed in the following while taking 
into account only the radial displacements of the particles in the tissue. The wave 
propagation within a tissue is assumed to be of the same density as the wave 
propagation velocity within a fluid. Longitudinal waves are defined through the 
following equation [87, 88]: 
2 2 2 2
2 2 2 2 2 2
1 1 1
.
ir r r r z c t
        
   
    
    (3.15) 
The wave velocity within a tissue is found as follows: 
 
  
2
12
.
1 1 2
ef
i
i i i
EE
c
 
    

  
 
    (3.16) 
The modulus of elasticity for the tissue 20.6 / ,E N cm  Poisson’s coefficient  
0.45   , density 31000 /i kg m    [89], thus 477 /ic cm s  and wave number 
1287 .i ik c s
   Further, the constant is found: 
2
2 1
2
4
287 .i
z
k cm



         (3.17) 
If the solution for the tissue is proposed to be the following: 
   
2
cos ,
i n t
n n
z
z
P r e b
  


        (3.18) 
then a differential equation of Bessel is obtained from (3.19) for the determination of 
function  nP r : 
2 2
2
2 2
1 4
0.n n i n
z
n
P P k P
r r


 
      
 
     (3.19) 
When taking into consideration totally different 
ik   values than that for fluid 
k , independent solutions  nJ r and  nY r  to Equation (3.19) are obtained [90]. 
The general solution to differential Equation (3.19) can be formulated as follows: 
       
2
cos .
i n t
n n n n n
z
z
B iA J r iY r e b
   


     
   
(3.20)
 
The real part of potential 
n  is as follows:  
   
2
sin cos cos .n n n
z
z
n t n t b

     

          (3.21) 
where 
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     
     
,
.
n n n n n
n n n n n
r A J r B Y r
r B J r A Y r
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  
  

 
     (3.22) 
The velocities of particles and pressure are proposed to be as follows: 
   
   
sin
,
2
cos cos
n
rna n
n
z
v r n t
r
z
r n t b
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
   

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   
     (3.23) 
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sin cos .
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z
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    (3.24) 
Equations (3.11) and (3.23) contain hyphens which denote fluxions of the 
Bessel’s functions with respect to their arguments but not with respect to r . Thus 
Equations (27) must be supplemented as follows: 
     
     
,
.
n n n n n
n n n n n
r A J r B Y r
r B J r A Y r
  
  
    

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     (3.25) 
Equations (3.22) and (3.23) contain separated solutions when 1,2,...n    The 
general solution for the tissues is obtained by summing up in the way it was done for 
the fluid in (3.14). 
4.3. Conditions for the Existence of the Proposed Solution  
Functions (3.12), (3.13), (3.23) and (3.24) used to define the velocities and 
pressures of the wave flow, in principle, remain unchanged over time t , thus steady-
state flows in a fluid and in a tissue are the same at any moment in time only turned 
at certain angle. For this reason, the solution can be found at any t, for instance, at 
0.t   In this case, by using 
or r  and 1r r  (i.e., on the surface of the tube and on 
the surface of the fluid-tissue contact), we obtain results in the Fourier series for 
functions   ,rs ov r   1 ,rav r   1ap r . We hereby refer to the sums when 1,2,3...n   
Factors (multipliers) at cos , sinn n   represent the Fourier coefficients for these 
functions. If two    functions in range  ;    are equal, their Fourier coefficients 
are equal as well. And if all the coefficients are equal, all the functions in the function 
space  2L G are equal, too [91]. For the purpose of determining functions constants 
, , , ,n n n nC D A B  1,2,...n   are available. The following are the conditions that must 
be met by these functions: 
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 
2
sin cos ,rs o
z
z
v r b

 

      (3.26) 
   1 1 ,rs rav r v r        (3.27) 
   1 1 .rs rap r p r        (3.28) 
The first condition (3.26) was determined from (3.4). The following is obtained 
from (3.27) and (3.28), when 1,2,3...n  : 
     
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     (3.29) 
Here, the incorporation of (3.22) and (3.25) results in a homogenous system of 
4 linear algebraical equations for the calculation of constants , , ,n n n nA B C D . The 
system of Equations (3.29) has nonzero solution only in case if the determinant is as 
follows: 
       
       
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 
 
   
   



 
This is possible only for certain values of 
1r , and only for a few 1,2,3...n  , 
but not all. Thus, conditions (3.27) and (3.28) cannot be met simultaneously. 
It is assumed that the condition regarding pressure definitely must be met, but 
equations of velocities and displacements when 
or r  and 1r r  are compulsory not 
for every  . Let us assume that gaps occur in between the fluid and the tube, and 
between the fluid and the tissue. Since the flow is in a steady state, the above-
mentioned gaps that are hereinafter referred to as caverns, represent cavities filled 
with some gas or vapor and acquire the constant shape that remains unchanged over 
time. They tend to rotate jointly with the sliding motion of the tube, and their position 
should follow after the tube or tissue is moved in the opposite direction. Further 
research involves the calculation of caverns at the moment of time 0.t    
 
4.4. Description of Caverns 
The cavern beside the tube is defined as the difference of velocities as follows 
[91]: 
   
2 2
sin cos cos ,rs o
z z
z z
v r b b G
 
   
 
 
   
(3.30)
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when             and   
2
sin cos 0rs o
z
z
v r b

 

   for every 
other .  Let us denote the reduced velocity as follows: 
,
2
cos
rs
rs
z
v
v
z
b



        (3.31) 
then: 
   
 
sin , ,
sin 0, ; .
rs o
rs o
v r G
v r
      
      
     
    
      

     
   (3.32) 
where    is the angle to the centre of the tube cavern, 2  is the angular width 
of the tube cavern. 
The reduced velocity of the tissue is similarly defined: 
2
cos
ra
ra
z
v
v
z
b



        (3.33) 
and the tissue cavern equals: 
  , ,
0, ; .
ra rs
ra rs
v v G
v v
     
     
      

     
    (3.34) 
Definitions (3.32) and (3.34) show that the functions of caverns  G   and 
 G   are defined in analogous manner, thus further calculations involve the 
description of tissue cavern  G   only, whereas the tube cavern is offered too, but 
only by writing up an asterisk. 
If  G   represents an integrated periodic function within range [ , ]    
, the following can be formulated: 
   
1
sin cos ,o j j
j
G e g j e j  


        (3.34) 
where ,j jg e  represent real numbers. In order to apply the outside conditions 
(3.26) and (3.27), function (3.35) must be regrouped into the periodic function over 
the entire range [ , ]    as follows: 
  , ,ra rsv v f               (3.36) 
   
1
cos sin ,
2
o
n n
n
a
f a n b n  


       (3.37) 
where coefficients of Fourier series are as follows: 
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   
   
cos cos ,
sin sin .
n
n
a f x nxdx G x nxdx
b f x xdx G x nxdx
  
  
  
  



 

 

 


  


 
 
    (3.38) 
Incorporation of (3.35) into (3.38) results in the following: 
1 1
, 0,1,2,...n j ajn j ajn
j j
a g h e q n
 
 
        (3.39) 
Where: 
       sin sin sin sin
cos sin sin sin
2 , ,
ajn
j n j n j n j n
h
j n j n
n n j j
j n
n j
   
   

   
  
 
  
  
sin sin
sin 2 cos , ,ann
n n
h n n j n
n n
 
 

 
   
 
  
 
       cos sin cos sin
cos sin cos sin
2 , ,
ajn
j n j n j n j n
q
j n j n
n n j j
j n
n j
   
   

   
  
 
  
  
2 2
2
cos 2 sin 2 cos sin
2 , .
2
ann
n n n n
q j n
n n
   


      
The second equation in system (3.39) after function  G x  is incorporated into 
it, allows other Fourier coefficients to be calculated as follows: 
1 1
, 1,2,...n j bjn j bjn
j j
b g h e q n
 
 
        (3.40) 
Here: 
       cos sin cos sin
sin sin sin sin
2 , ,
bjn
j n j n j n j n
h
j n j n
n n j j
j n
n j
   
   

   
  
 
  
 
2 2
2
cos 2 sin 2 sin sin
2 , ,
2
bnn
n n n n
h j n
n n
   


      
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       sin sin sin sin
sin sin cos sin
2 , ,
bjn
j n j n j n j n
q
j n j n
n n j j
j n
n j
   
   

   
  
 
  
  
 
sin sin
sin 2 cos , .bnn
n n
q n n j n
n n
 
 

 
   
 
  
If the position and the length of the cavern, i.e., numbers   and   are the 
selected ones, then all the ,ajn ajnh q  , ,bjn bjnh q are known values. 
The following can be obtained from (3.39), when 0n  : 
1
sin cos
sin .
j j
o o
j
g j e j
a e j
j
 
 




      (3.41) 
All the formulas proposed here can also be applied for the tube cavern by using 
   and 

 instead of   and  . 
4.5. The Equations for the Determination of the Caverns  
Next, particles’ velocities (3.12) and pressure (3.13) in a fluid as well as 
particles’ velocities (3.23) and pressure (3.24) in a tissue are to be found. For this 
purpose, constants , , , ,n n n nC D A B  1,2,...n  need to be found. Since the solutions 
must meet Equations (3.26), (3.27) and (3.28) for every t  and  , there are 6 equations 
(factors at sin n  and cos n ) for every n . Taking into account the caverns, Equation 
(3.27) is replaced with Equation (3.36), and Equation (3.26) with the following 
equation [92]  
   sin ,rs ov r f 
        (3.42) 
where 
   
1
cos sin .
2
o
n n
n
a
f a n b n  
 
  

       (3.43) 
This is a Fourier series analogous to series (3.37) proposed above. This way, 
the equation of velocities when 
or r  is satisfied for every t  and   if 
   
   
,
1,2,3,...
,
n n o n n o n n
n n o n n o n
C I kr D K kr b
n
C K kr D I kr a


    

  
 ,  (3.44) 
and the constant 
1 1   and 0n   if 1.n   The first equation in Formula (3.44) 
represents multipliers at sin n , and the second one represents multipliers  at cos .n  
Moreover, new constants have been incorporated into (3.44) 
n nC C k   ,  .n nD D k    
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The equation of velocities (3.27) for the tissue when 
1r r , while taking into 
account the cavern and Equation (3.36), is formulated with the following system of 
equations: 
       
       
1 1 1 1
1 1 1 1
,
.
n n n n n n n n n
n n n n n n n n n
A J r B Y r C I kr D K kr b
A Y r B J r C K kr D I kr a
 
 
       

       
  (3.45) 
where 1,2,3,...n   and new constants are incorporated, too 
, .n n n nA A B B       
The equation of pressure (3.28) is considered to remain the same when 
1r r , 
thus, taking into account the new constants, it results in the following:  
       
       
1 1 1 1
1 1 1 1
[ ] 0,
[ ] 0.
n n n n n n n n
n n n n n n n n
C K kr D I kr A Y r B J r
C I kr D K kr A J r B Y r
  
  
    

   
  (3.46) 
Here, .
ik


   
The main problem here is the computation of constants , , ,n n n ng e g e
 
that are 
used to define caverns. For this reason, it is worth eliminating , , ,n n n nC D A B  from 
the system of 6 equations (3.44), (3.45), (3.46). Formulation (3.46) can be further 
expressed as follows: 
,
,
n n n n n
n n n n n
A M C N D
B N C M D
  

 
       (3.47) 
where 
2 2
;n n n nn
n n
I J K Y
M
J Y




  
2 2
.n n n nn
n n
K J I Y
N
J Y




 
Here, arguments for all the Bessel functions ,n nI K  are 1kr , and for functions 
,n nJ Y  arguments are 1.r   
The following can be expressed from the system of equations: 
 
 
,
.
n n n n n n
n n n n n n
C M a N b
D N a M b


 
 
   

  
      (3.48) 
Here: 
2 2
,nn
n n
K
M
I K


 
  
2 2
n
n
n n
I
N
I K


 
 
and arguments for each and every Bessel function are .okr   
Incorporating (3.47) and (3.48) into (3.45) results in the following equations: 
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 
 
0,
0.
n n n n n n
n n n n n n
X a Y b b
Y a X b a


 
 
    

   
      (3.49) 
Here the following denotations are used: 
,
,
n n n n n
n n n n n
X M R N S
Y N R M S
  

 
       (3.50) 
     
     
1 1 1
1 1 1
,
.
n n n n n n
n n n n n n
R I kr J r M Y r N
S K kr J r N Y r M
 
 
     

    
    (3.51) 
Numbers ,n nX Y  can be calculated, thus only two equations (3.49) are available 
for finding the constants , , ,n n n ng e g e
 
 for every 1,2,3,...n  . If 1,2,...,n N  , then 
total 2N  equations and 4N  parameters are obtained apart from four numbers    , 
  ,   and  . 
The system of equations (3.49), as a result of incorporation of (3.39) and (3.40), 
turns out to be as follows: 
   
   
1 1
1 1
1 1
1 1
,
.
N N
ajn n bjn n j ajn n bjn n j
j j
N N
bjn j bjn j n n
j j
N N
ajn n bjn n j ajn n bjn n j
j j
N N
ajn j ajn j n n
j j
h X h Y g q X q Y e
h g q e Y
h Y h X g q Y q X e
h g q e X
 
 
     
 
 
     
 
 

   


   


    



  

 
 
 
 
   (3.52) 
Constants 
oe  and oe

 have been incorporated into the solution to cavern (3.35) 
and tube’s cavern  G  , having a physical meaning, such as the movement in the 
radial direction at a constant speed. Consequently, these constants must be equal to 
zero. The same is true about constants , .o oa a

 It can be obtained from (3.41) that if 
0oa  , it follows: 
1
sin cos
sin .
N
n n
o
n
g n e n
e n
n
 



      (3.53) 
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4.6. Displacements of the Caverns 
Velocities have been investigated that were described in Equation (3.23) as 
periodic functions of argument  n t  . Such an argument shows that with the 
change in angle  by 2  or change in time by 2T   , all the functions remain 
unchanged. Accordingly, it can be stated that the steady-state solution somewhat turns 
around the z axis without experiencing any changes.  
For the sake of simplicity, the calculation of caverns involved, 0t   which in 
turn resulted in a somewhat instantaneous picture of cavern (3.35) where 0oe  . 
Since the cavern turns at the same angular velocity as the entire steady-state solution, 
the law of the cavern motion (3.35) must be generalized in the following manner: 
     
1 1
, sin cos .r j j
j j
G t g j t e j t    
 
 
        (3.54) 
Here, it is understood that 0oe   was incorporated. When 1r r  , the velocities 
are  , , .ra rs rv v G t                (3.55) 
The integration of (3.54) and (3.55) by time results in the reduced displacements 
of the tissue and the fluid as follows: 
   
1 1
1 1
sin cos .ra rs n n
n n
c
e n t g n t
     
  
 
 
         (3.56) 
Here, c  represents the constant that generally can be a function of angle  . 
As it can be understood from (3.53), the actual displacements can be assumed to be 
as follows: 
   
1 1
2
sin cos cos .ra rs n n
n n z
z
e n t g n t c b

     

 
 
 
      
 
  (3.57) 
Here, b  represents the amplitude of the sliding displacement of the tube. 
Incorporating 0t   allows obtaining the form of the cavern when          
: 
1 1
2
sin cos cos .as n n
n n z
z
c e n g n b

  

 
 
 
   
 
     (3.58) 
The tube’s cavern is defined in ideally the same manner: 
1 1
2
sin cos cos .sv n n
n n z
z
c e n g n b

  

 
  
 
 
   
 
    (3.59) 
The determination of constants ,c c 

 requires additional physical data that 
should be associated with the pressure and gas flow within the caverns. 
Since 0  , as otherwise it would mean that the cavern simply does not exist, 
and   , as in this case the cavern would be present around the entire perimeter of 
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 , then, as it can be understood from (3.53), in order to have 0,oe   it must be as 
follows: 
sin cos 0, 1,2,3,...n ng n e n n        (3.60) 
If cos 0n   and cos 0n   at every 1,2,3,...,n N , then it can be derived 
from (3.60) that tan ,n ne g n   tann ne g n
    and incorporated into (3.52). If 
sin 0n   and sin 0,n   1,2,3,...,n N  , then it can be expressed as ,n ng g

, 
and result in equations with the unknown quantities ,n ne e

 . However, there is always 
a good chance that any of the factors tan , tann n   (or 1 tan ,1 tann n  ) can 
turn out to be infinitely huge and impede our computation. The simplest option is 
apparently to write 2N  equations (3.52) and then to supplement them with N  
equations (3.60) and N  following equations: 
sin cos 0, 1,2,3,...n ng n e n n 
        (3.61) 
This way, the system of 4N  linear equations is obtained with 4N  unknown 
quantities , , , .n n n ng e g e
 
  
When making an assumption regarding the existence of caverns, the outside 
conditions (3.26) and (3.27) were modified, but the equation of pressure (3.28) was 
kept the same. This equation, as a matter of fact, must also be slightly modified if the 
solution of the cavern gas dynamics is to be taken into account. This would in turn 
affect the entire system of equations described above in this chapter. 
 
Fig. 56.  Formation of caverns (that of the tube is the solid line, that of the tissue is the dotted 
line) 
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Both caverns, that of a tube and that of a tissue, are described by a general 
system of equations. The movement and the appearance of the caverns is shown in 
Fig. 56. Both caverns are interdependent and cannot be investigated separately one by 
one. 
The calculation of the pressure at the tip of the waveguide, the pressure at the 
beginning of the tissue, and pressure as the function of distance in the infinite fluid 
and environment considering the cavern phenomena are shown in Figures 57, 58 and 
59.  
 
 
Fig. 57. Pressure on the tip of the waveguide. 
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Fig. 58. Pressure at the beginning of the tissue. 
 
Fig. 59.  Pressure as the function of distance. The dotted line is in an infinite (non-limited) 
fluid. 
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4.7. Calculation of the Size of the Cavern 
Solving the task of modeling led us to the observation that during the operation 
of the ultrasonic system, a cavity containing tenuous gas, here referred to as the 
cavern, is formed at the wall of the blood vessel. Section 3.7 offers the calculation of 
its width. 
 
Fig. 60. Formation of the cavern where 1) is the wall of the blood vessel; 2) is a liquid 
environment (blood); 3) is the tip of the waveguide; 4) is the cavern. 
 
The thickness of the outside layer can be calculated when the surface is 
vibrating at 23.185 kHz frequency in its own plane as follows: 
  
2
3
4
0.73 10
0.23 10 2.3
13.7 10
cm

 


    

 
Here, viscosity of water is incorporated 
2
20.73 10 cm
s
    at a temperature of 
35o C . The vibration frequency is 413.7 10 rad
s
   . 
4.8. Summary of Chapter 3 
The mathematical model of the waveguide and its operational environment, in 
this particular case – human blood, confined by biological human tissues (the wall of 
a blood vessel) has been developed.  
In the course of the solution of the mathematical task, a highly important 
phenomenon was revealed: with the waveguide operating under the resonant regime, 
a pocket containing tenuous gas of a size of up to 2.3 µm is formed at the wall of the 
blood cell that keeps sliding along the wall of the blood cell at a speed of the 
waveguide rotation. It can have a significant effect on the energy balance in the 
medium in which the waveguide is operated and may also significantly affect the 
absorption of drugs through the wall of the blood vessel and may exert influence on a 
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large scale thus enhancing the effect that the ultrasonic system has on the occluding 
malformation of the vascular walls. 
This phenomenon has not yet been addressed and requires to be experimentally 
investigated in further research. 
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5. EXPERIMENTAL INVESTIGATION OF THE TUBE-SHAPED 
WAVEGUIDE WIRE WAVEGUIDE SYSTEM 
5.1. Equipment Used for the Research  
The ultrasonic system under consideration has been designed to operate jointly 
with Ultrasound Generator VT-400 and a non-standard transducer constructed in situ. 
The descriptions of the ultrasound generator capable of operating under the pulsed 
regime and of the piezo-transducer are offered below. Unless specified otherwise, all 
the experiments under consideration here involved these two non-standard parts of the 
system. 
5.1.1. Ultrasound Generator VT-400 
 
Fig 61. Ultrasound generator VT-400. 
The main technical characteristics of the ultrasound generator are described in 
Table 2. 
 
Table 2. The technical characteristics of ultrasound generator VT-400 
Supply voltage, V 200-240 
Output power, W Up to 400 
Number of channels 1 
Output frequency, kHz 15-60 
Dimensions, mm 300×425×135 
Capacity, W 500 
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5.1.2. The Ultrasound Transducer 
 
Fig. 62. The construction of an ultrasonic blood vessel cleaning system, where: 1) is the 
conical concentrator 2) is a piezo ceramics ring, 3) is a copper ring, 4) is the pressing 
element. 
 
Fig. 63. Dimensions of the piezo ring used in the transducer of the ultrasonic system.  
The ultrasound transducer is comprised of the conical concentrator (1) and four 
piezo ceramic rings PZT-4 (2) with the diameter of 25 mm and thickness of 5 mm that 
are fitted on the conical concentrator and spaced by copper rings with the diameter of 
0.5 mm and paper insulation. The entire system is reinforced by the fastening 
component made of stainless steel with a thickness of 16 mm which is smaller by 
1 mm in diameter (4). 
5.2.  Effect of Low Intensity Cavitation on Isolated Human Arteries 
The results described/presented in this chapter have been published in the 
following article: Bubulis, A., Garalienė, V., Jurėnas, V., Navickas, J., Giedraitis, S. 
Effect of Low-Intensity Cavitation on the Isolated Human Thoracic Artery in Vitro. 
Ultrasound in Medicine and Biology 43, 2017, 1040–1047. 
The experiments have been conducted on isolated human thoracic artery 
samples. The samples were collected during conventional myocardial 
revascularisations in patients who underwent coronary artery bypass grafting in the 
Department of Cardiothoracic and Vascular Surgery at the Lithuanian University of 
Health Sciences. All the patients chose to sign a letter of informed consent. The study 
was approved by the Regional Ethics Committee of Biomedical Research on the 5th 
of November 2010, licence No. BE-2-64, in Kaunas, Lithuania.  
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Fig. 64. Experimental set-up for the ultrasonic treatment of blood vessel samples, where 1) is 
the EZ-Bath Tissue/Organ Bath System; 2) are tissue baths; 3) is the pre-warming system 
(thermostat); 4) is the L-BRAM4 Bridge Amplifier; 5) is the Ultrasonic processor 
VCX130PB; 6) is the Piezoelectric transducer and its probe; 7) is a PC monitor. 
 
Fig. 55. The experiment scheme, where:  1) is the EZ-Bath Tissue/Organ Bath 
System; 2) is the bath pre-warming system; 3) is the ultrasonic processor VCX130PB; 4) is 
the L-BRAM4 Bridge Amplifier; 5) is the piezoelectric transducer and its probe; 6) is a PC. 
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Fig. 66. The scheme of our experiment, where 1) is the water tank; 2) is the physiological 
fluid; 3) is the ultrasound transducer; 4) is the blood vessel; 5) are blood vessel holders. 
The artery samples were obtained from a total of 152 patients. Their age average 
was 67.3 ± 9.6 years. Women accounted for 30.7 percent of the total number of the 
patients involved. 
Vascular preparation. For the purpose of investigating blood vessel segments 
in vitro, a tissue/organ bath system produced by the Global Town Microtechnology 
Company (Sarasota, FL, USA) was used. The artery samples were collected at the 
ambient temperature from patients undergoing coronary artery bypass grafting. 
Afterwards, the samples were gently cleansed of the connective tissue, then carefully 
cut into 3–4 mm long rings and hung on a vascular holder. The upper hook of the 
vascular holder was attached to an isometric force transducer. The samples were 
dipped into 5 ml tissue baths filled with Tyrode’s solution that was warmed to 37°C 
and continuously bubbled with 100 % oxygen. The composition of the solution was 
as follows (in mM): NaCl, 137; KCl, 5.4; CaCl2, 1.8; MgCl2, 0.9; Tris HCl, 10; and 
glucose, 5; pH = 7.4. Prior to starting the experiments, the blood vessel samples were 
allowed to equilibrate for at least 45–60 min. Throughout the investigation period, the 
preparations were periodically (every 15 min) washed with fresh Tyrode’s solution. 
With the aim to examine the effect of the ultrasound, an irradiation to the side 
and the open end of the blood vessel was performed. For this purpose, the contraction 
and relaxation process was invoked, then, an equilibration period followed, and, 
finally, the isolated vascular samples were exposed to discontinuous ultrasound pulse 
for a period of ten or twenty seconds. The tip of the transducer was positioned at the 
distance of 0.5 cm to the sample surface or along the vessel lumen.  
Protocol. The first series of experiments involved studying the isometric 
contraction and relaxation effects in artery rings when phenylephrine-induced 
contraction was produced by zero, 10 and 20 min after exposing them to 10 s 
ultrasound pulse. Phenylephrine solution at 10-4 M concentration was used in all the 
experiments under consideration. Phenylephrine acts as a vasoconstrictor, i.e., it binds 
to α1-adrenoceptors located at the surface of sarcolemma, and activates the enzyme 
phospholipase C which is responsible for the synthesis of inositol 1,4,5-triphosphate 
(IP3). The latter affects inositol 1,4,5-triphosphate receptors (IP3R) that are localized 
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on the surface of the sarcoplasmic reticulum (SR) in the vascular smooth muscle and 
that prevail there [92, 93]. At the same time, the sarcolemma depolarizes, and external 
calcium enters through L-type Ca2+ channels into the cell. Due to the interaction of 
IP3 with IP3 receptors, the calcium ions entered into cytosol initiate Ca2+ release from 
the SR. Consequently, the more Ca2+ ions accumulate in the SR, the more of them 
should move into the cytoplasm during depolarization. As a result, the isometric 
contraction of the smooth muscle is forced to increase proportionally [94]. 
The effects of ultrasound on the functioning of the endothelium or slow (L-
type) calcium channels within the vessel rings was assessed by examining the 
relaxation response to carbachol, an agonist of muscarinic acetylcholine receptors [95] 
and diltiazem, an inhibitor of the slow calcium channel [96]. Once the phenylephrine-
produced isometric contraction has reached its steady state, the above mentioned 
agents were added to the solution in a cumulative-concentration manner, at doses of 
10-7–10-4 M. The time course of the exerted force was recorded. The relaxation and 
isometric contraction forces were expressed in percentages and in mN (milinewtons), 
respectively, of the vasoconstrictor induced pre-contraction.   
Subsequently, the second series of experiments was undertaken. In order to 
determine whether the blocking of the slow calcium channel alters the effect that 
ultrasound irradiation has on the contraction force of vessel segments, the samples 
were pre-treated with diltiazem in accordance with the following scheme: after 
leaving the rings for 30 min in Tyrode’s solution to achieve their equilibration state, 
diltiazem was added into the bath at a concentration of 50 µM, and ultrasound was 
applied at 20 min after diltiazem had been added.  
In control groups, the vessel samples were taken from the same patients as in 
the experimental groups, and all the measurements were carried out in parallel.  
Drugs and chemicals used. Carbamylcholine chloride (carbachol), 
phenylephrine chloride (phenyleprhine) and diltiazem (CAS No. 42399-41-7) were 
obtained from Sigma-Aldrich Chemie (Taufkirchen, Germany). They were dissolved 
in deionised water to obtain a stock solution of 0.1 mM.  All the stock solutions were 
stored at a low temperature.  
Statistics. The statistical analysis was performed by using SPSS (Statistical 
Package for the Social Sciences) software packed version 10.0. All the values 
obtained were expressed as means ± SEM. The statistical significance was defined as 
P<0.05. 
Results 
The effects of ultrasound irradiation on the contraction force in the isolated 
human thoracic samples are detailed below. 
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Fig. 67. The effect of 10-second US irradiation with and without diltiazem on the response of 
the contraction force in the isolated human a. thoracica rings (n=20) pre-contracted with Ph 
(10-4M) 10 min after the start of the US; n is the number of artery samples. *p < 0.01. The 
results are expressed as means ± SE. 
The results depicted in Fig. 67 show a significant increase in the contraction 
force in the ultrasound group (51.6%, p < 0.01) exposed to 10-second ultrasound 
irradiation pulses and where vasoconstrictor phenylephrine (Ph, 10-4 M) was used 
10 min after applying the pulse.  
Similar data was obtained with the exposure of the artery segments to 20 s 
ultrasound irradiation, leading to the observation that, under the experimental 
conditions, the amount of ultrasound irradiation had no significant effect on the ratio 
of the contraction forces (12.4 ± 1.86 mN and 6.36 ± 1.3 mN, 48.4%, p < 0.01, 
respectively, in the groups exposed and not exposed to ultrasound) when the 
experimental groups were compared to the control groups.  
The time that passed between the ultrasound exposure and vasoconstriction was 
found not to influence the level of the contraction ratio. Phenylephrine used 
immediately after the exposition to ultrasound resulted in an increased contraction 
force to 20.0 ± 2.8 and 9.2 ± 1.6 mN in the control group, respectively (ratio of ~ 2:1, 
54 %, p <0.01). Meanwhile, the increase of the time up to 20 minutes proved the 
assumption to be true that the effects of ultrasound are relatively long-lasting when 
compared to the artery lifespan in vitro. Therefore, in the case under consideration 
here, the isometric contraction of blood vessel samples in response to Ph remained 
significantly increased (16.63 ± 3.0 mN) compared to the ultrasound-free group (8.0 
± 1.66 mN), but were lower (minus 3.34 mN, 16.7 %) than the measurements taken 
immediately after irradiation with ultrasound. 
To determine the influence of the slow calcium channel blocking on the 
isometric contraction of artery samples exposed to ultrasound irradiation, diltiazem, a 
well-known inhibitor of slow calcium channels, was used. For this purpose, blood 
vessel samples in both groups were immersed in a diltiazem solution of 50 µM 
concentration for 30 min. Throughout this period, the experimental group (20 min 
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after the immersion in diltiazem solution) was treated with 10-second ultrasound 
irradiation. The response of isometric contraction is presented in Fig. 67. Thereby, 
pre-treatment with diltiazem resulted in a smaller increase of contraction in both 
groups (12.16 ± 2.2 mN in the experimental group and 5.4 ± 1.04 mN in the US-free 
group, compared to the data presented in Fig. 67, where the experimental results were 
obtained under the same conditions, though the data values did not differ among 
themselves (p > 0.05). It means that the basic amount of calcium involved in the 
contraction mechanism is not from the outside of the cells, but is released from the 
internal resources, such as sarcoplasmic reticulum or mitochondria. Moreover, it 
means that this process is enhanced by ultrasound cavitation. 
The following trials were performed on the same vessel segments of the 
thoracic artery; however, the ultrasound irradiation was used along the vessel lumen. 
The recorded response showed that, under conditions of 10-second internal ultrasound 
irradiation, the augmentation of the contraction force more than doubles (~ 2.3:1) 
compared to the control (US-free; Ph was used 10 min after the exposure of the pulse 
of ultrasound). 
An increase of the external irradiation frequency from 20 kHz to 32.6 kHz 
caused a greater increase of isometric contraction, and the ratio of contraction forces 
under those conditions was 2.46:1 (at 20 kHz, it was ~ 2:1; Fig. 67).  
Consequently, the experimental results suggest that the isometric contraction of 
a smooth muscle in the isolated human a. thoracica segments is sensitive to the 
cavitation induced by the ultrasound pulse, and increases with the increase in 
ultrasonic frequency. 
The effects of ultrasound irradiation on the vascular smooth muscle relaxation 
induced by carbachol and diltiazem are detailed below. 
A hypothesis was raised that the low intensity cavitation induced by low-
frequency ultrasound could restore the endothelial dysfunction stemming from 
systemic atherosclerosis. For the purpose of verifying this hypothesis, carbachol (Ch), 
an agonist of muscarinic M receptors whose effects are realized through the 
endothelial-dependent release of relaxing factors based on nitric oxide, a key 
vasodilator, was used. [97]  
As studies have shown, the relaxation of blood vessels (as a response to Ch) 
treated with ultrasound irradiation is not unequivocal and is independent of the 
ultrasound frequency, irradiation time and the period of time passed since the start of 
exposition to ultrasound. 
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Fig. 68. a) Influence of 10-second US on the relaxation of isolated a. thoracica segments 
(n=15) induced by Ch (10-7 – 10-4M); the segments were pre-contracted with Ph (10-4 M) 
immediately after the start of US. b) Influence of 10-second US on the relaxation of isolated 
a. thoracica segments (n=14) induced by Ch (10-7 – 10-4M); the segments were pre-
contracted with Ph (10-4 M) 20 min after the start of the US pulse; n is the number of artery 
samples. The results are expressed as means ± SE. 
Accordingly, the data presented in Fig. 68a and Fig. 68b clearly shows that the 
time period from the start of irradiation with ultrasound to vasoconstriction has no 
significant effect on the smooth muscle relaxation process. 
Regardless of whether the blood samples were pre-contracted with Ph 
immediately after the start of the exposure to ultrasound or 20 min afterwards, a 
similar relaxation process was observed. Therefore, the relaxation began in all the 
groups at a dose of 10-7 M of Ch, and varied within the range of 3 % to 11 %. An 
increase in the Ch dose caused the relaxation to slightly increase, as well, and at a 
concentration of 10-4 M, the relaxation reached 22.5 % and 21.3 % in the ultrasound-
treated groups (in Fig. 68a and Fig. 68b, respectively). The differences between the 
control and the experimental groups as well as between the control groups in both 
events were not significant (p > 0.05). 
As it was noted above, internal ultrasound irradiation more than doubled (by 
approx. 2.3 times), and the increase in the contraction force compared to the control 
group was observed. Such a significant increase in isometric contraction indicates the 
increased number of free intracellular calcium ions that are generally involved in the 
smooth muscle contraction process [98]. However, a question arises whether the 
smooth muscle cells are able to sequestrate the excess Ca to naturally induce their 
relaxation; otherwise said, the question is whether the smooth muscle cells remain 
viable after their exposure to ultrasound. With the aim to answer this question, the 
relaxation process of segments was recorded in real time when an experimental group 
was treated with internal ultrasound for 10 seconds and 10 min after the 
vasoconstrictor (phenylephrine) was used. The obtained results are presented in 
Fig. 69. 
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Fig. 69. Influence of 10-second internal US irradiation on the relaxation of blood vessel 
segments (n=13) over time; a vasoconstrictor (Ph, 10-4 M) was used 10 min after the start of 
the US pulse; n is the number of artery samples. The results are expressed as means ± SE. 
Thus a single dose of phenylephrine was observed to induce contraction of 
26.16 mN and 11.61 mN, on average, in the ultrasound-treated and control groups, 
respectively (the ratio is approx. 2.25:1, 55.6 %, p <0.01). Given such a difference in 
contraction forces, it was speculated whether or not this increased intercellular 
calcium concentration would slow the relaxation movement to some extent and 
thereby slow the relaxation of segments in the treated group. The taken measurements 
showed the relaxation magnitude to be very similar in both groups. At 40 min, it 
reached 82.5 % and 93 % in the ultrasound group and the control group, respectively. 
This difference was not statistically significant.  
A similar response of the smooth muscle to carbachol was observed while using 
internal as well as higher frequency ultrasound irradiation (32.6 kHz). Accordingly, 
the obtained experimental data showed that low intensity cavitation induced by low 
frequency ultrasound irradiation has no effect on endothelium-dependent relaxation 
in isolated human blood vessels. 
For the the next experimental study, diltiazem was used. Interestingly, diltiazem 
was observed to decrease the isometric contraction of the blood vessel segments by 
approx. 25 percent in the control group, and approx. 17.3 percent in the ultrasound-
treated group in comparison to those without diltiazem.  
Meanwhile, the relaxation dynamics of the vessel segments treated by diltiazem 
was not different from the control group (which included vessel segments not treated 
by diltiazem) (Fig. 70). In other words, ultrasound irradiation has no effect on relaxing 
the properties of diltiazem. Thus using it in a concentration-dependent manner 
gradually relaxed the segments, and its influence did not differ from the control group. 
For instance, at a dose of 10-4 M of diltiazem, the smooth muscles exposed to 
ultrasound were observed to relax to 50.4 percent. In the control group, the results 
were very similar (47.5 percent).  
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Fig. 70. Influence of diltiazem (Dilt.) on the relaxation of artery segments (n=12); a 
vasoconstrictor (Ph, 10-4 M) was used 10 min after the start of 10-second US exposure; n is 
the number of artery samples. The results are expressed as means ± SE. 
It follows from this study that low intensity cavitation induced by low-
frequency ultrasound exposure does not affect the relaxation of smooth muscle 
associated with a slow calcium channel. 
Experiments conducted on isolated human artery thoracic segments in vitro are 
influenced by low-intensity cavitation induced by low-frequency (4–6 W/cm2, 20 kHz 
and 32.6 kHz) ultrasound. The obtained results show that the isometric contraction of 
those segments was increased by the factor of two (in the case of internal and 32.6 kHz 
stimulation) compared to the segments not irradiated with ultrasound. The influence 
of ultrasound treatment on the contraction force was observed to decrease 
insignificantly due to the pre-treatment of the segments with diltiazem (an inhibitor 
of slow calcium channels). When used in a concentration-dependent manner, 
diltiazem was observed not to modify the relaxation dynamics of the smooth muscle 
exposed to ultrasound. The use of ultrasound of the above mentioned parameters did 
not improve the endothelial relaxing properties. 
5.3. Experimental Investigation of Tube-Shaped Wavegude Displacement Using 
Polytec PSV 3D Laser Vibrometer 
With the aim to determine the resonance frequency for the maximum 
displacement toward the z axis, experiments were conducted on the experimental table 
of the Polytec PSV 3D laser vibrometer. The experimental investigation setup is 
shown in Fig. 71. It consists of the following: 1 is the Polytec PSV 3D laser 
vibrometer; 2 is the ultrasound waveguide system; 3 is the magnetic holder of the 
transducer; 4 is the anti-vibration table. To secure the reflection of the laser beam from 
the tip of the waveguide, the reflection film was glued on the tip. The mass of the 
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glued reflection film is insignificant, thus it has no implication for the results of the 
experiment. First of all, the FFT analysis was undertaken to determine the peaks of 
the system within the respective frequency range (15–30 kHz). Afterwards, the 
maximum displacement toward the z axis was determined. To determine the 
displacements when the transducer was excited with operating voltage, the peak was 
investigated in the time scanning mode. 
The experimental investigations were conducted under several sets of different 
conditions and in different points of interest. As Fig. 71 shows, the waveguide was 
investigated under free conditions inserted in tube which was filled with water. In both 
cases, the displacement of the tip of the waveguide was measured. In ANother case, 
the screw of the housing of the waveguide and the housing of the waveguide (the lug) 
was investigated to determine the effect of THE housing (the lug) on the displacement 
of the waveguide.  
 
Fig. 71. The experimental setup. 1) A polytec machine (laser sources); 2) a 
waveguide; 3) a holder; 4) an anti-vibration table, 5) a PC. 
 
 
Fig. 72. Polytec PSV 3D laser vibrometer experimental scheme. 
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Ultrasonic blood vessels cleaning system was excited by a periodic chirp type 
signal with an amplitude of 10 volts to determine the FFT analysis of the tip of the 
waveguide.  
 
 Fig. 73. (FFT analysis of the tip of waveguide in the range of 15–30  kHz ) Determining the 
resonance frequency for the best displacement on the z axis. 
Our analysis of the results revealed the following three resonances of the system 
– at 23.10 kHz, at 20.33 kHz and at 23.04 kHz. The maximum displacements along 
the z axis were recorded at a frequency of 23.10 kHz (with the error of 0.0815 kHz 
when compared to the result of modeling when using the Finite Element Method). 
Since the principal functionality of the ultrasonic system is to trespass the thrombus 
in the frontal direction (along the z axis), this particular frequency is hereinafter 
considered to be the operational frequency of the system.  
Meanwhile, maximum displacements in the directions of x and y axes (meaning 
that the operational end of the waveguide is drawing an ellipse of the maximum radius 
which in turn enables to assume that the cavitation process is the most vigorous at this 
frequency) were observed at 20.5 kHz. This particular frequency is to be used if the 
primary task of the operation is not to trespass the thrombus in the frontal direction 
(the z axis) but rather to clean the walls of the occluded blood vessel.  
As our results showed, the maximum displacements along the z axis occur at a 
resonance frequency of 23.19 kHz with the amplitude of 21 nm.  
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Fig. 74. x, y, and z axis displacement on the resonant frequency at the end point of the 
waveguide. 
When the ultrasonic blood vessel clearing system was induced by the sine type 
signal with an amplitude of 100 V, the resonance frequency of 23.19 kHz was 
recorded. The tip of the waveguide under investigation provided maximum 
displacement towards the z axis amounting up to 7.02 micrometer (see Fig. 74).  
Our computational mathematical analysis and experimental trials revealed that 
elliptical movement is characteristic for the tip of the waveguide. It was determined 
by the imperfections of the steel surface, and the mechanical wave transmission 
through the threaded connection between the screw connecting the waveguide to a 
concentrator and a transducer. In comparison to the results of the computational 
analysis, more significant displacements were observed in the  course of the 
experiment under realistic conditions. 
 
 Fig. 75. x, y, and z axis displacement on the resonant frequency at the fixing element (screw) 
of the ultrasound system. 
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Fig. 76. x, y, and z axis displacement on the resonant frequency at the construction element 
(lug) of the ultrasound system. 
The housing screw and the housing lug were investigated with the aim to 
determine the influence of these components on the displacements of the waveguide. 
The same excitation signal as described in the section above was used. The obtained 
results showed displacements of the screw towards z of 1.4 μm (Fig. 75) and the 
displacement of the housing end towards the z axis of 1.8 μm (see Fig. 76). 
Consequently, the housing can be considered to exert influence on the displacements 
of the tip of the waveguide toward the z axis.  
 
Fig. 77. x, y, and z axis displacement on the resonant frequency at the end point of the 
waveguide filled with water. 
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 Fig. 78. x, y, and z axis displacement on the resonant frequency at the end point of the 
waveguide filled with water, placed in a water-filled catheter. 
 
Fig. 77 illustrates the experiment conducted on the waveguide filled with water. 
In this case, the maximum displacement of 11.02 μm was determined. The results 
obtained through investigation on the waveguide filled with water and placed in a tube 
which was also filled with water are shown in Fig. 78. In this particular case, the 
maximum displacement of 2.1 μm was recorded; the wave period was observed to get 
shorter by more than 1.5 times. The investigation also revealed that the waveguide is 
damped when it is excited under conditions that are very similar to its real operating 
environment (being surrounded by fluid within the blood vessel). As the experiment 
delivered positive results, it makes a sound basis for undertaking further investigation, 
including the computational analysis of a newly designed innovative ultrasound 
system under realistic operating conditions. 
5.4. Amplitude-Frequency Characteristic 
To experimentally confirm the modeling accomplished by means of the Finite 
Element Method and the results of non-contact laser system, the amplitude-frequency 
characteristic was determined. The longitudinal vibration mode in a frequency range 
of 15–26 kHz was measured. The slowed acoustic signal of the suspended tube-
shaped waveguide tip (rested upon the sensor) was measured, or, otherwise, the 
pressure on the unidirectional sensor (accelerometer) RTF KD 91, with its own 
resonance frequency of 50 kHz, and sensitivity of 0.5mv/1m per s2 was investigated. 
The experimental platform and the schematic view is presented below in Figures 79 
and 80 of this Chapter.  
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Fig. 79. The experimental setup, where 1) is a transducer; 2) is the Sensor RTF KD91; 
3) is a sensor holder; 4) is the Osciloscope Picoscope 3424; 5) is a generator; 6) is a PC. 
 
 
Fig. 80. A scheme of the amplitude-frequency characteristic experiment. 
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Findings and Results of the Experiment 
The amplitude frequency of the waveguide while the generator is working at a 
different level of power is shown in Figures 81 and 82. 
 
 
 
Fig. 81. Amplitude-frequency characteristic for 20% of generator power. 
 
 Fig. 82. Amplitude-frequency characteristic for 40% of generator power. 
A piezo transducer produces through the waveguide a certain energy boost in a 
certain range. In this particular case, it is from 19.5 kHz to 22 kHz with the generator 
operating at 20 % of its power. By providing more power to the system, up to 22 kHz, 
displacements in the frequency range were so huge that they even caused impact on 
the acoustic sensor thus making it impossible to record the amplitude-frequency 
characteristic. However, in the range from 22 kHz to 30 kHz, the operation of the 
system was excellent and featured the maximum amplitude (in millivolts) at 23.2 kHz. 
This in principle matches the results obtained through the Finite Element Method with 
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some error which possibly occurred due to deformations suffered by the waveguide 
during measurements.  
Once the amplitude-frequency characteristic was found, the nodes and 
antinodes were determined at the maximum quantity (vibration to the sensor). The 
results of the measurements are presented in Fig. 83. 
 
Fig. 83. Nodes and antinodes at 23.185 kHz frequency, where 1) are nodes; 2) are 
anti-nodes. 
 
In Fig. 83, the standing waves can be seen with the system operating at a 
resonance frequency of 23.185 kHz. Displacements along the z (frontal) axis cause 
flexing vibrations to occur that have their own specific nodes and antinodes. At these 
antinodes, the ceramic rings (distinguished by the generation of extremely low friction 
when in contact with any other surfaces) tend to obtain the steady state. The variation 
in frequency makes them change the position. In general, they are positioned at steps 
of 20 mm. 
The experiment showed three contact points to exist. This serves as a suitable 
visual aid to show how many active contact areas there are that absorb energy due to 
their friction.  
5.5. Experimental Investigation of Waveguide Wire Influence to Surrounding 
Fluids 
The results described/presented in this chapter have been published in the 
following article: Kargaudas, V., Bubulis, A., Navickas, J., Vitkus, L., Venslauskas, 
M. Theoretical and Experimental Investigation of Tube-Shaped Waveguide Wire. 
Journal of Measurements in Engineering 5, 2017, 257–265.  
5.5.1. Mechanical and Thermal Influence on Blood 
During the operation of the device under research, the cavitation process and 
the friction between the waveguide and the surrounding fluids cause temperature to 
rise dramatically. Human body temperature above 42 °C is well known to cause 
fatality as red blood cells undergo in vivo hemolysis [99]. Taking this into 
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consideration, the next series of experiments on human blood were undertaken. For 
this purpose, Thermovisor FLIR SC7000, a generic generator, a PC and the tube-
shaped waveguide system was used. Fig. 84 shows the setup and a schematic view of 
the experiment accomplished. 
 
Fig. 84. The experimental setup where 1) is the waveguide in a tube filled with water;  
2) is the Thermovisor FLIR SC7000; 3) is a generator; 4) is a PC. 
 
 
Fig. 85. A schematic view of the experiment. 
 
The first experiment was carried out while using the operating system inside 
the tube with the diameter of 3 mm, which in its structure was very similar to a human 
artery. The data gathered in the course of the experiment revealed that it takes as little 
as 4 seconds to reach the lethal temperature of 42 °C (with the starting point being 
36 °C).  
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Fig. 86. Fluid temperature per time, °C. 
 
As the next step, a series of figures presented below indicates what happens to 
the red blood cells (erythrocytes) after exposing blood to ultrasound for 30 s. The 
same experiment setup as described in Figs. 84 and 85 was used. 
After blood had been affected with ultrasound, blood samples were gathered, 
and a thin 1-cell layer was spread on a transparent glass plate and checked with an 
electronic microscope. The pictures obtained with a microscope can be seen in Fig. 
87, Fig. 88 and Fig. 89. 
 
Fig. 87. A microscopic photo of erythrocytes exposed to ultrasound,  
the control group. 
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Fig. 88. A microscopic photo of erythrocytes exposed to ultrasound 
after 15 s of influence of the cavitation. 
 
Fig. 89. A microscopic photo of erythrocytes exposed to ultrasound 
after 30 s of influence of the cavitation. 
The microscopic pictures of human blood taken after exposing blood to 
ultrasound generated by the ultrasonic system with a tube-shaped waveguide revealed 
that, after 15 seconds of treatment, blood clots have been formed, and, after 30 seconds 
of treatment, some cells have totally been destroyed. Consequently, it is vital to find 
and establish the safe operating regime for the ultrasonic vascular clearing system of 
the innovative design offered here. Bearing all the above in mind, the experiments 
described above in Chapter 4.4.2 were undertaken. 
5.5.2. Determination of the Safe Operating Regime for the Ultrasound System 
The second experiment (within the same experimental setup as described in 
Chapter 4.4.1) was carried out with the aim to determine the safe (as the human body 
temperature above 42 °C is well known to cause fatality as red blood cells undergo in 
vivo hemolysis [99]) operating regime of the ultrasonic system under research. Figures 
90 and 91 show the results of the experiment.  
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Fig. 90. The temperature inside a tube when operating under pulsed regime with 60 % on, 
40 % off. 
 
Fig. 97. The temperature inside a tube when operating under pulsed regime with 40 % on, 
60 % off. 
It was experimentally found that the safe operating regime, i.e., one which 
enables to avoid heating of the environment to the temperature harmful for the 
medium (blood) and the surrounding tissues, is achieved when the system is 40 % on, 
and 60 % off over the period of 1 second. 
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5.6. Impedance Analysis of the Waveguide in Different Working Regimes 
Electrical impedance represents an electric method of finding the resonance 
frequency. Since the piezo ring is the electric condenser, measuring the impedance 
(reactance) allows finding the resonance frequencies of the system. Our measurements 
used the impedance analyzer Wayne Kerr 6500b. Its main parameters are presented in 
the table below. 
 
Table 3. Technical specifications of the impedance analyzer Wayne Kerr 6500b 
Frequency range, Hz 20 Hz to 20 mHz 
Accuracy of set frequency, % 0.005% 
Measurements per second 20 
 
The experimental platform was comprised of the following two components: 
the transducer and the waveguide attached to it together with the impedance analyzer 
Wayne Kerr 6500b that provided the power supply to the transducer. 
 
Fig. 92. The experimental setup, where 1) is the transducer; 2) are magnet holders; 3) is a 
tube-shaped waveguide; 4) is a plastic tube filled with water; 5) is the Wayne Kerr 6500b 
unit. 
 
 
Fig. 93. A schematic view of the experiment. 
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In the following Figures 94–99, the dotted line shows the impedance resistance 
while the solid line shows the phase.  
 
Fig. 94. Impedance analysis of the ultrasound system with a free waveguide in the air. 
Our impedance analysis showed three main resonance modes – at ~ 20.852 kHz, 
22.085 kHz and 23.807 kHz. These findings prove and (with a small deviation) 
confirm the results gathered during the experiment described in Chapter 4.3. The 
following figures show the results of the experiment that was carried out while using 
the waveguide in different positions: a) inserted in a tube filled with water b) bent 
c) clamped d) variations in between the first 3 positions.  
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Fig. 95. Impedance analysis of the ultrasound system with a clamped-tip waveguide in the 
air. 
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Fig. 96. Impedance analysis of the ultrasound system with a bent waveguide in the air. 
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Fig. 97. Impedance analysis of the ultrasound system while the waveguide is placed in a tube 
filled with water. 
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Fig. 98. Impedance analysis of the ultrasound system while the bent waveguide is placed in a 
tube filled with water. 
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Fig. 99. Impedance analysis of the ultrasound system while the bent waveguide with a 
clamped tip is placed in a tube filled with water.  
Our analysis showed an obvious decrease in impedance under conditions when 
the waveguide is less likely to vibrate, i.e., when the waveguide under research is bent, 
clamped at its tip, inserted in the tube filled with water, etc.  
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Fig. 100. Impedance analysis of the ultrasound system while the waveguide with a 
waveguide is in different positions: 1) the black continuous line – empty and free; 2) the grey 
line – bent; 3) bent, placed into a tube filled with water and clamped. 
Fig. 100 indicates differences among the experimentally measured impedances 
with the waveguide placed in different positions. For instance, when the bent 
waveguide is tested, the first resonance mode is observed to be shifted by approx. 
0.4 kHz (i.e., the required frequency is decreased). Meanwhile, the experimentally 
determined resonance frequency of 23.185 kHz when suppressing the waveguide 
under three different regimes (i.e., bent, immersed in water and with its tip being 
immobilised) does not result in desirable displacements anymore. It means that, in this 
particular case, the drop in impedance requires for the frequency to be changed, i.e., 
the frequency of 21.25 kHz must be used instead as it had featured positive results. In 
general, this particular experiment led to the following observations: 
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1. The position of the waveguide inserted in the blood vessel can be, in 
principle, determined on the grounds of impedance while comparing the 
actually operating waveguide to the experimentally taken measurements of 
the bent and immobilized waveguide. The lower is the impedance (in 
ohms), the greater is the obstacle the waveguide is confronting. In the 
resonance mode, the totally diminished impedance indicates that the tip of 
the waveguide has confronted some hard object, such as plaque lamella. 
2. Certain positions of the waveguide (such as clamped at the tip, curved, etc.) 
cause the resonance frequency of the waveguide to vary. Observation of the 
impedance during the operation enables to work under the resonance 
regime at all times without the need to listen to the operation of the 
waveguide by using some external sensor or without using an X-ray, which 
in turn makes the operation safer and more patient-friendly. 
5.7. Summary of Chapter 4 
The results obtained through the Finite Element Method regarding 
displacements of each individual component of the waveguide – the tip of the tube, 
the lug and the screw – at the moment of operation, were proved experimentally in 
the thesis. The maximum displacement along the frontal z axis (7.02 μm) was found 
to occur at an operational frequency of 23.185 kHz.  
When testing the ultrasonic system in the natural operational medium, namely, 
human blood, the critical temperature of 42 degrees at the tip of the waveguide was 
achieved in less than 3 s with the waveguide being vibrated in a continuous mode. For 
this reason, it is absolutely necessary to ensure the pulsed operating regime, i.e., the 
one that enables to avoid heating of the environment (blood) and the surrounding 
tissues up to the harmful temperature. It was experimentally found that such an 
operating regime is achieved when the system is 40 % on, and 60 % off over the period 
of 1 second. 
The investigation of the ultrasonic system in several different positions (for 
instance, with the clamped tip in the air, in a tube filled with water, etc.) allowed 
finding changes in impedance resistance depending on the position of the tube. 
Although a higher number of similar experiments are required to be carried out while 
using more sensitive equipment, this is nevertheless a highly viable and promising 
data as the technique proposed herein allows for ‘anticipating’ if the waveguide is 
reclined against an occlusive malformation, if it is bent over while in the human artery, 
etc., which reduces the need for using harmful X-rays and the infusion of certain 
reagents into the human body.  
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CONCLUSIONS 
1. Currently, cardiovascular diseases represent the leading cause of death and 
disability among humans before their age of 65 years. Moreover, the World 
Health Organization predicts a further growth of cardiovascular morbidity. 
For this reason, the comprehensive review of the relevant literature and 
patient information was undertaken. As a result, it revealed an obvious need 
for the development of an invasive ultrasonic waveguide enabling to 
trespass the thrombus while operating at both frontal and radial directions, 
allowing to feed and deliver any required amount of drugs to the damaged 
site of the blood vessel, and at the same time enabling to suck away the 
scurf of the broken occluding malformations. 
2. The tube-shaped waveguide of the innovative design with the length of 
260 mm and thickness of 1.5 mm has been developed with the holes drilled 
at its operational tip through which an unlimited amount of drugs can be 
fed to the site of the waveguide operation. The FEM modeling of the 
simplified waveguide acting in close to real-life conditions (in a muscle-
surrounded blood vessel filled with blood) showed that the best frequency 
for the greatest amount of frontal and transverse pressure is 24.970 kHz. 
While working in such a resonant mode, the best waveguide tip point 
displacement towards the z axis (forward) is 8.3 μm. 
3. The mathematical modeling of the waveguide allowed to observe and 
explore the phenomenon of the caverns, i.e., in the course of cavitation at 
the end of the waveguide, the pocket containing tenuous gas is formed that 
lags behind the pocket containing tenuous gas and which formed at the tip 
of the waveguide moving in circles at a certain angle in theta degrees.  
Further calculations enabled us to obtain the width of such a cavern which 
was equal to 2.3 μm. 
4. The ultrasound effect on live human blood vessels was explored 
experimentally. A 2.4 times better response to contraction-inducing 
substances was observed in the case when a blood vessel was pre-treated 
with ultrasound. Measurements of the vibrations taken by a laser non-
contact measurement system at different parts of the ultrasonic system 
under research proved the results of computational modeling using FEM to 
be true. The maximum displacement at the frontal z axis under a resonance 
frequency of 23.815 kHz was found to amount up to 7.9 μm. The safe 
operating regime for the tube-shaped waveguide was established 
experimentally. Blood was found not to heat above the destructive 
temperature of 42 degrees Celsius at the site of the waveguide operation (at 
its tip) when the ultrasound generator was operated in a pulsed mode, i.e., 
40 % on, and 60 % off over its period of activity. 
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Annexes 
Annex 1 
Table 4.  Causes of death — diseases of the circulatory system, EU residents, 
2013 [1] 
GEO/TIME 2011 2012 2013 2014 
European Union (28 countries) 395.33 394.25 383.35 373.62 
Belgium 311.36 308.89 301.2 281.89 
Bulgaria 1,181.53 1,168.03 1,085.8 1,131.02 
Czech Republic 713.31 704.21 670.25 615.18 
Denmark 293.87 286.78 267.68 256.59 
Germany 406.25 404.07 433.08 403.54 
Estonia 752.45 745.41 718.16 699.56 
Ireland 352.8 351.32 343.85 309.91 
Greece 445.51 448.34 404.74 381.41 
Spain 271.78 271.03 253.07 244.99 
France 223.03 221.55 212.87 202.93 
Croatia 759.53 691.12 694.56 678.55 
Italy 343.8 343.58 322.79 310.14 
Cyprus 417.77 402.17 341.57 351.84 
Latvia 891.33 920.61 914.55 882.7 
Lithuania 911.45 900.56 894.09 848.82 
Luxembourg 365.93 332.2 310.76 296.93 
Hungary 778.94 779.4 778.24 761.52 
Malta 484.36 519.43 405.82 372.42 
Netherlands 293.45 288.58 282.75 271.73 
Austria 437.9 450.24 443.8 418.07 
Poland 638.89 652.35 635.34 591.39 
Portugal 315.74 323.6 304.77 305.76 
Romania 1,039.91 1,039.17 968.58 951.3 
Slovenia 463.12 462.42 451.54 451.26 
Slovakia 743.63 712.13 711.63 654.55 
Finland 422.21 411.85 388.22 378.79 
Sweden 376.23 371.39 354.05 338.32 
United Kingdom 284.96 284.6 276.4 264.94 
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Neighbour countries  
Liechtenstein 368.89 325.82 230.49 296.38 
Norway 314.59 311.69 288.5 272.63 
Switzerland 301.07 303.82 294.71 280.04 
Serbia 1,048.48 1,017.68 954.13 931.61 
Turkey 470.66 340.36 375.89 : 
 
Table. 5.  Causes of death — diseases of the circulatory system, EU residents, 
younger than 65 years, 2013 [1] 
GEO/TIME 2011 2012 2013 2014 
European Union (28 countries) 49.42 48.44 47.09 45.67 
Belgium 34.98 33.1 32.34 29.75 
Bulgaria 175.05 161.39 156.25 166.85 
Czech Republic 73.23 69.78 66.51 61.48 
Denmark 31.97 29.7 28.56 28.68 
Germany 41.3 40.49 40.13 38.77 
Estonia 96.69 97.08 97.67 94.3 
Ireland 37.5 37.07 35.37 34.01 
Greece 54.41 54.07 51.31 50.48 
Spain 28.16 27.91 27.67 27.37 
France 26.69 25.92 25.01 24.39 
Croatia 74.75 73.38 68.4 67.24 
Italy 28.7 28.11 26.7 26.15 
Cyprus 36.31 35.88 30.87 34.34 
Latvia 163.98 156.9 153.13 149.38 
Lithuania 145.81 142.2 133.85 127.43 
Luxembourg 35.02 33.19 35.17 28.85 
Hungary 117.15 111.77 105.81 106.87 
Malta 44.74 48.52 35.04 35.07 
Netherlands 30.29 29.9 27.56 25.93 
Austria 36.93 34.63 34.46 31.89 
Poland 91.48 95.17 91.47 84.75 
Portugal 29.68 28.39 28.88 34.25 
Romania 122.78 120.93 115.9 114.95 
Slovenia 42.51 37.75 36.03 35.38 
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Slovakia 87.94 84.78 85.63 80.11 
Finland 50.47 47.38 44.48 43.28 
Sweden 31.93 30.34 30.74 28.96 
United Kingdom 38.47 37.18 37.57 36.82 
Neighbour countries  
Liechtenstein 31.36 28.06 21.62 20.73 
Norway 27.99 29.12 24.85 23.86 
Switzerland 24.6 25.11 23.33 23.15 
Serbia 105.22 102.62 99.86 101.26 
Turkey 60.84 58.58 62.24 n/a 
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Annex 2 
Mathlab program Soundwaves in Tissue Limited Fluid calculations 
 
clc 
% Pradiniai ir Kraujo duomenys 
rn=0.075; % cm 
r1=0.3;  % cm min 
% r1=0.5; % cm max 
fH=21800; % Daznis 
lamdt=4.0;  % lambda cm, duotas atstumas z asyje 
ro=1000; % kraujo tankis kg/m3 
%av=0.0006; % amplitude x asyje cm 
%bv=0.00025; % amplitude y asyje cm 
om=2*pi*fH; %daznis rad/s 
cf=147000; %garso greitis kraujyje cm/s 
kf=om/cf; % 1/cm 
kk=4*pi^2/lamdt^2-kf^2;% bangos skaicius 
k=sqrt(kk); % 1/cm 
cs=om/k;  % redukuotas greitis 
cfssant=cf/cs; % greiciu santykis 
  
% Audinys 
E=0.6; % tamprumo modulis N/cm2 
Em2=E*10000; % tamprumo modulis N/m2 
ni=0.45; 
roi=1050; % audinio tankis kg/m3 
cik=(1-ni)*Em2/((1+ni)*(1-2*ni)*roi); 
cim=sqrt(cik);  % garso greitis m/s 
ci=cim*100 ; % greitis cm/s 
ki=om/ci; 
kap=sqrt(ki^2-(2*pi/lamdt)^2); % bangos skaicius 
  
% Santykiai 
ros=roi/ro; % tankiu santykis audinys/kraujas 
ks=kap/k; % bangu skaiciai 
chi=ks/ros; %  
  
% BESELIO funkcijos 
% argumentai 
krn=k*rn; % k*r0 
kr1=k*r1; % k*r1 
pr1=kap*r1; % kapa*r1 
  
Nma=3; % ! Formato aprasymas 
for nc=1: Nma 
% argumentas k*r0 
Inn=besseli(nc,krn); 
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Knn=besselk(nc,krn); 
Innb=besseli(nc-1,krn)-Inn/krn; % isvestine Pazymejimas b 
Knnb=-besselk(nc-1,krn)-Knn/krn; % isvestine 
% argumentas k*r1 
In=besseli(nc,kr1);% 
Kn=besselk(nc,kr1);%; 
Inb=besseli(nc-1,kr1)-In/kr1; % isvestine 
Knb=-besselk(nc-1,kr1)-Kn/kr1; % isvestine 
% argumentas kapa*r1  Pazymejimas p 
Jn=besselj(nc,pr1); 
Yn=bessely(nc,pr1); 
Jnb=besselj(nc-1,pr1)-Jn/pr1; % isvestine 
Ynb=bessely(nc-1,pr1)-Yn/pr1; % isvestine 
  
Mn=chi*(In*Jn-Kn*Yn)/(Jn^2+Yn^2); 
Nn=chi*(Kn*Jn+In*Yn)/(Jn^2+Yn^2); 
MMn(nc)=Mn; % Masyvas  Mn(n) 
NNn(nc)=Nn; % Masyvas  Nn(n) 
Mvn=Knnb/(Innb^2+Knnb^2); % v reiskia vingis, t.y. arg k*r0 
Nvn=Innb/(Innb^2+Knnb^2); 
Rn=Inb-Jnb*Mn-Ynb*Nn; 
Sn=Knb-Jnb*Nn+Ynb*Mn; 
RRn(nc)=Rn; % Masyvas  Rn(n) 
SSn(nc)=Sn; % Masyvas  Sn(n) 
XXn(nc)=Mvn*Rn-Nvn*Sn; 
YYn(nc)=Nvn*Rn+Mvn*Sn; 
end 
XXn; 
YYn; 
MMn; 
NNn; 
RRn; 
SSn; 
  
% Kavernu padetis ir ilgiai 
tekzL=0;  % teta z  vamzdelio kavernos padetis laipsniais 
tekL=140 ; % teta audinio kavernos padetis laipsniais 
tekz=tekzL*pi/180; % radianais 
tek=tekL*pi/180;  % radianais 
  
lamzL=120; % vamzd. kav. ilgis laipsniais 
lamL=115; % audinio kav. ilgis laipsniais 
lamz=lamzL*pi/180; % radianais 
lam=lamL*pi/180; % radianais 
spau=1; 
if spau==1 
disp(['Maziausios kavernos vertes parinktos']) 
disp(['  ']) 
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end 
disp(['Vamzdelio kavernos padetis tekz=',num2str(tekzL),... 
     ', kavernos ilgis lamz=',num2str(lamzL),' laipsniu']) 
disp(['Audinio   kavernos padetis tek=',num2str(tekL),... 
     ', kavernos ilgis lam=',num2str(lamL),' laipsniu']) 
  
%ha, qa, hb, qb skaiciavimai: teta=tt, lamda=md 
% Vamzdelio kavernos duomenys 
tt=tekz; 
md=lamz; 
for nc=1:Nma 
    for jc=1:Nma 
        if jc==nc 
        ha(jc,nc)=sin(2*nc*tt)*(sin(nc*md)/nc)*(cos(nc*md)-... 
        sin(nc*md)/(nc*md)); 
        else 
        ha(jc,nc)=sin((jc+nc)*tt)*sin((jc+nc)*md)/(jc+nc)+... 
        sin((jc-nc)*tt)*sin((jc-nc)*md)/(jc-nc)-... 
        
2*cos(nc*tt)*sin(nc*md)*sin(jc*tt)*sin(jc*md)/(nc*jc*md); 
        end 
        if jc==nc 
        qa(jc,nc)=md+cos(2*nc*tt)*sin(2*nc*md)/(2*nc)-... 
        2*(cos(nc*tt)*sin(nc*md))^2/(nc*nc*md); 
        else 
        qa(jc,nc)=cos((jc+nc)*tt)*sin((jc+nc)*md)/(jc+nc)+... 
        cos((jc-nc)*tt)*sin((jc-nc)*md)/(jc-nc)-... 
        
2*cos(nc*tt)*sin(nc*md)*cos(jc*tt)*sin(jc*md)/(nc*jc*md); 
        end 
         
        if jc==nc 
        hb(jc,nc)=md-cos(2*nc*tt)*sin(2*nc*md)/(2*nc)-... 
        2*(sin(nc*tt)*sin(nc*md))^2/(nc*nc*md); 
        else 
        hb(jc,nc)=cos((jc-nc)*tt)*sin((jc-nc)*md)/(jc-nc)-... 
        cos((jc+nc)*tt)*sin((jc+nc)*md)/(jc+nc)-... 
        
2*sin(nc*tt)*sin(nc*md)*sin(jc*tt)*sin(jc*md)/(nc*jc*md); 
        end 
        if jc==nc 
        qb(jc,nc)=sin(2*nc*tt)*(sin(nc*md)/nc)*(cos(nc*md)-... 
        sin(nc*md)/(nc*md)); 
        else 
        qb(jc,nc)=sin((jc+nc)*tt)*sin((jc+nc)*md)/(jc+nc)-... 
        sin((jc-nc)*tt)*sin((jc-nc)*md)/(jc-nc)-... 
        
2*sin(nc*tt)*sin(nc*md)*cos(jc*tt)*sin(jc*md)/(nc*jc*md); 
        end 
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    end 
    % Galiniu kavernu verciu koef. 
    hcp(nc)= sin(nc*tt+nc*md)-sin(nc*tt)*sin(nc*md)/(nc*md); 
    hcm(nc)= sin(nc*tt-nc*md)-sin(nc*tt)*sin(nc*md)/(nc*md); 
    qcp(nc)= cos(nc*tt+nc*md)-cos(nc*tt)*sin(nc*md)/(nc*md); 
    qcm(nc)= cos(nc*tt-nc*md)-cos(nc*tt)*sin(nc*md)/(nc*md); 
end 
haz=ha; % vamzdelio kavernos duomenys 
qaz=qa; 
hbz=hb; 
qbz=qb; 
hcpz=hcp; 
hcmz=hcm; 
qcpz=qcp; 
qcmz=qcm; 
% Audinio kavernos duomenys 
tt=tek; 
md=lam; 
for nc=1:Nma 
    for jc=1:Nma 
        if jc==nc 
        ha(jc,nc)=sin(2*nc*tt)*(sin(nc*md)/nc)*(cos(nc*md)-... 
        sin(nc*md)/(nc*md)); 
        else 
        ha(jc,nc)=sin((jc+nc)*tt)*sin((jc+nc)*md)/(jc+nc)+... 
        sin((jc-nc)*tt)*sin((jc-nc)*md)/(jc-nc)-... 
        
2*cos(nc*tt)*sin(nc*md)*sin(jc*tt)*sin(jc*md)/(nc*jc*md); 
        end 
        if jc==nc 
        qa(jc,nc)=md+cos(2*nc*tt)*sin(2*nc*md)/(2*nc)-... 
        2*(cos(nc*tt)*sin(nc*md))^2/(nc*nc*md); 
        else 
        qa(jc,nc)=cos((jc+nc)*tt)*sin((jc+nc)*md)/(jc+nc)+... 
        cos((jc-nc)*tt)*sin((jc-nc)*md)/(jc-nc)-... 
        
2*cos(nc*tt)*sin(nc*md)*cos(jc*tt)*sin(jc*md)/(nc*jc*md); 
        end 
         
        if jc==nc 
        hb(jc,nc)=md-cos(2*nc*tt)*sin(2*nc*md)/(2*nc)-... 
        2*(sin(nc*tt)*sin(nc*md))^2/(nc*nc*md); 
        else 
        hb(jc,nc)=cos((jc-nc)*tt)*sin((jc-nc)*md)/(jc-nc)-... 
        cos((jc+nc)*tt)*sin((jc+nc)*md)/(jc+nc)-... 
        
2*sin(nc*tt)*sin(nc*md)*sin(jc*tt)*sin(jc*md)/(nc*jc*md); 
        end 
        if jc==nc 
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        qb(jc,nc)=sin(2*nc*tt)*(sin(nc*md)/nc)*(cos(nc*md)-... 
        sin(nc*md)/(nc*md)); 
        else 
        qb(jc,nc)=sin((jc+nc)*tt)*sin((jc+nc)*md)/(jc+nc)-... 
        sin((jc-nc)*tt)*sin((jc-nc)*md)/(jc-nc)-... 
        
2*sin(nc*tt)*sin(nc*md)*cos(jc*tt)*sin(jc*md)/(nc*jc*md); 
        end 
        
    end 
    % Galiniu kavernu verciu koef. 
    hcp(nc)= sin(nc*tt+nc*md)-sin(nc*tt)*sin(nc*md)/(nc*md); 
    hcm(nc)= sin(nc*tt-nc*md)-sin(nc*tt)*sin(nc*md)/(nc*md); 
    qcp(nc)= cos(nc*tt+nc*md)-cos(nc*tt)*sin(nc*md)/(nc*md); 
    qcm(nc)= cos(nc*tt-nc*md)-cos(nc*tt)*sin(nc*md)/(nc*md); 
 end 
ha; 
qa; 
hb; 
qb; 
  
% LYGTYS 
a11=haz(1,1)*XXn(1)+hbz(1,1)*YYn(1); 
a12=haz(2,1)*XXn(1)+hbz(2,1)*YYn(1); 
a13=haz(3,1)*XXn(1)+hbz(3,1)*YYn(1); 
a14=qaz(1,1)*XXn(1)+qbz(1,1)*YYn(1); 
a15=qaz(2,1)*XXn(1)+qbz(2,1)*YYn(1); 
a16=qaz(3,1)*XXn(1)+qbz(3,1)*YYn(1); 
  
a21=haz(1,2)*XXn(2)+hbz(1,2)*YYn(2); 
a22=haz(2,2)*XXn(2)+hbz(2,2)*YYn(2); 
a23=haz(3,2)*XXn(2)+hbz(3,2)*YYn(2); 
a24=qaz(1,2)*XXn(2)+qbz(1,2)*YYn(2); 
a25=qaz(2,2)*XXn(2)+qbz(2,2)*YYn(2); 
a26=qaz(3,2)*XXn(2)+qbz(3,2)*YYn(2); 
a31=haz(1,3)*XXn(3)+hbz(1,3)*YYn(3); 
a32=haz(2,3)*XXn(3)+hbz(2,3)*YYn(3); 
a33=haz(3,3)*XXn(3)+hbz(3,3)*YYn(3); 
a34=qaz(1,3)*XXn(3)+qbz(1,3)*YYn(3); 
a35=qaz(2,3)*XXn(3)+qbz(2,3)*YYn(3); 
a36=qaz(3,3)*XXn(3)+qbz(3,3)*YYn(3); 
  
a41=haz(1,1)*YYn(1)-hbz(1,1)*XXn(1);  
a42=haz(2,1)*YYn(1)-hbz(2,1)*XXn(1);  
a43=haz(3,1)*YYn(1)-hbz(3,1)*XXn(1); % Linkėjimai vis dar 
skaitantiems cia 
a44=qaz(1,1)*YYn(1)-qbz(1,1)*XXn(1); 
a45=qaz(2,1)*YYn(1)-qbz(2,1)*XXn(1);  
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a46=qaz(3,1)*YYn(1)-qbz(3,1)*XXn(1); 
a51=haz(1,2)*YYn(2)-hbz(1,2)*XXn(2);  
a52=haz(2,2)*YYn(2)-hbz(2,2)*XXn(2); 
a53=haz(3,2)*YYn(2)-hbz(3,2)*XXn(2); 
a54=qaz(1,2)*YYn(2)-qbz(1,2)*XXn(2); 
a55=qaz(2,2)*YYn(2)-qbz(2,2)*XXn(2); 
a56=qaz(3,2)*YYn(2)-qbz(3,2)*XXn(2); 
a61=haz(1,3)*YYn(3)-hbz(1,3)*XXn(3);  
a62=haz(2,3)*YYn(3)-hbz(2,3)*XXn(3); 
a63=haz(3,3)*YYn(3)-hbz(3,3)*XXn(3);  
a64=qaz(1,3)*YYn(3)-qbz(1,3)*XXn(3); 
a65=qaz(2,3)*YYn(3)-qbz(2,3)*XXn(3); 
a66=qaz(3,3)*YYn(3)-qbz(3,3)*XXn(3); 
  
%    g1z     g2z     e1z     e2z     e3z     g1       g2     
g3      e1      e2     
Ama=[a11     a12     a14     a15     a16   hb(1,1) hb(2,1) 
hb(3,1) qb(1,1) qb(2,1); 
     a21     a22     a24     a25     a26   hb(1,2) hb(2,2) 
hb(3,2) qb(1,2) qb(2,2); 
     a31     a32     a34     a35     a36   hb(1,3) hb(2,3) 
hb(3,3) qb(1,3) qb(2,3); 
     a41     a42     a44     a45     a46   ha(1,1) ha(2,1) 
ha(3,1) qa(1,1) qa(2,1); 
     a51     a52     a54     a55     a56   ha(1,2) ha(2,2) 
ha(3,2) qa(1,2) qa(2,2); 
     a61     a62     a64     a65     a66   ha(1,3) ha(2,3) 
ha(3,3) qa(1,3) qa(2,3); 
   hcpz(1) hcpz(2) qcpz(1) qcpz(2) qcpz(3)  0       0       0        
0      0     ;   % vamzd. kav.virs 
   hcmz(1) hcmz(2) qcmz(1) qcmz(2) qcmz(3)  0       0       0        
0      0     ;  % vamzd. kav. apac 
     0       0       0       0       0     hcp(1) hcp(2) 
hcp(3)    qcp(1) qcp(2)  ; % audinio kav. virs 
     0       0       0       0       0     hcm(1) hcm(2) 
hcm(3)    qcm(1) qcm(2) ]; % audinio kav. apac  
  
e3=-0.096921; 
g3z=-2.2104; 
  
 Bma=[-pi*YYn(1)-g3z*a13-e3*qb(3,1); -g3z*a23-e3*qb(3,2) ; -
g3z*a33-e3*qb(3,3) ; ... 
     pi*XXn(1)-g3z*a43-e3*qa(3,1);-g3z*a53-e3*qa(3,2) ; -
g3z*a63-e3*qa(3,3); ... 
     -g3z*hcpz(3); -g3z*hcmz(3); -e3*qcp(3); -e3*qcm(3) ]; 
egs=Ama\Bma; 
egslin=egs'; 
g1z=egs(1); 
  
 
126 
 
g2z=egs(2); 
e1z=egs(3); 
e2z=egs(4); 
e3z=egs(5); 
g1=egs(6); 
g2=egs(7); 
g3=egs(8); 
e1=egs(9); 
e2=egs(10); 
% Furje koef. an, bn, anz, bnz pagal ju aprasyma 
for jn=1:3 
    San(jn)=g1*ha(1,jn)+g2*ha(2,jn)+g3*ha(3,jn)+... 
        e1*qa(1,jn)+e2*qa(2,jn)+e3*qa(3,jn); % =pi*an 
    Sbn(jn)=g1*hb(1,jn)+g2*hb(2,jn)+g3*hb(3,jn)+... 
        e1*qb(1,jn)+e2*qb(2,jn)+e3*qb(3,jn);  % =pi*bn 
    Sanz(jn)=g1z*haz(1,jn)+g2z*haz(2,jn)+g3z*haz(3,jn)+... 
        e1z*qaz(1,jn)+e2z*qaz(2,jn)+e3z*qaz(3,jn); % =pi*anz 
    Sbnz(jn)=g1z*hbz(1,jn)+g2z*hbz(2,jn)+g3z*hbz(3,jn)+... 
        e1z*qbz(1,jn)+e2z*qbz(2,jn)+e3z*qbz(3,jn);  % =pi*bnz      
  
end 
Anfu= San/pi; % Furje eilutes koef. an 
Bnfu=Sbn/pi; % Furje eilutes koef. bn 
Anfuz= Sanz/pi; % Furje eilutes koef. anz - su zvaigzdute 
Bnfuz=Sbnz/pi; % Furje eilutes koef. bnz - su zvaigzdute 
  
% KONTROLE 
Delta=[1, 0 ,0]; 
nj=3; 
kontr1=Anfuz(nj)*XXn(nj)+Bnfuz(nj)*YYn(nj)+Bnfu(nj)+Delta(nj)*
YYn(nj); % turi buti 0 
kontr2=Anfuz(nj)*YYn(nj)-Bnfuz(nj)*XXn(nj)+Anfu(nj)-
Delta(nj)*XXn(nj); % turi buti 0 
  
for jn=1:3 
    var=(RRn(jn))^2+(SSn(jn))^2; 
    ccnbr=-(Bnfu(jn)*RRn(jn)+Anfu(jn)*SSn(jn))/var; 
    CCnbr(jn)=ccnbr; 
    ddnbr=(Bnfu(jn)*SSn(jn)-Anfu(jn)*RRn(jn))/var; 
    DDnbr(jn)=ddnbr; 
    AAnbr(jn)=ccnbr*MMn(jn)-ddnbr*NNn(jn); 
    BBnbr(jn)=ccnbr*NNn(jn)+ddnbr*MMn(jn); 
end 
CCnbr;  
DDnbr;  
CCn=CCnbr*cs;  
DDn=DDnbr*cs; 
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disp(['Sprendinio skystyje konst. C1=',num2str(CCn(1)),';  
C2=',num2str(CCn(2)),';  C3=',num2str(CCn(3))]) 
disp(['Sprendinio skystyje konst. D1=',num2str(DDn(1)),';  
D2=',num2str(DDn(2)),';  D3=',num2str(DDn(3))]) 
AAnbr;  
BBnbr;  
omka=om/kap;  
AAn=AAnbr*omka;  
BBn=BBnbr*omka;  
disp(['Sprendinio audinyje konst. A1=',num2str(AAn(1)),';  
A2=',num2str(AAn(2)),';  A3=',num2str(AAn(3))]) 
disp(['Sprendinio audinyje konst. B1=',num2str(BBn(1)),';  
B2=',num2str(BBn(2)),';  B3=',num2str(BBn(3))]) 
  
for nc=1:3 
Ife=besseli(nc,krn);  
Kfe=besselk(nc,krn);  
CIK(nc)=CCn(nc)*Ife-DDn(nc)*Kfe;  
SIK(nc)=CCn(nc)*Kfe+DDn(nc)*Ife;  
Ife1=besseli(nc,kr1);  
Kfe1=besselk(nc,kr1);  
CIK1(nc)=CCn(nc)*Ife1-DDn(nc)*Kfe1;  
SIK1(nc)=CCn(nc)*Kfe1+DDn(nc)*Ife1;  
  
Jfe=besselj(nc,kr1);  
Yfe=bessely(nc,kr1);  
CAB(nc)=ros*(AAn(nc)*Jfe+BBn(nc)*Yfe); 
SAB(nc)=ros*(AAn(nc)*Yfe-BBn(nc)*Jfe);  
  
Jfk=besselj(nc,pr1);  
Yfk=bessely(nc,pr1);  
Alfan(nc)=AAn(nc)*Jfk+BBn(nc)*Yfk;  
Betan(nc)=BBn(nc)*Jfk-AAn(nc)*Yfk; 
end 
CIK; 
SIK; 
CIK1; % Cn*In-Dn*Kn kai r=r1; koef. prie slegio cos(n*teta) 
SIK1; % Cn*Kn+Dn*In kai r=r1; koef. prie slegio sin(n*teta) 
CAB; 
SAB; 
Alfanr=Alfan*ros; % tankiu santykis*alfan; koef. prie slegio 
cos(n*teta) 
Betanr=Betan*ros; % tankiu santykis*betan; koef. prie slegio 
sin(n*teta) 
KnnG=besselk(1,krn); % Beselio funkcija K1 kai r=r0 
KnnbG=-besselk(0,krn)-KnnG/krn;  
dbsk=cs*KnnG/KnnbG; %daugiklis skaciuojant slegi kai r=r0, 
begaliniame sk. 
  
 
128 
 
KnnG1=besselk(1,kr1); % Beselio funkcija K1 kai r=r1 
dbsk1=cs*KnnG1/KnnbG; %daugiklis skaciuojant slegi kai r=r1, 
begaliniame sk. 
  
% SLEGIS KAIP KAMPO FUNKCIJA - - - - - - 
Njt=500; 
for jt=1:Njt % slegis kaip kampo funkcija 
    tet=-pi+2*pi*(jt-1)/(Njt-1); 
    TetL(jt)=tet*180/pi; 
    preds=CIK(1)*cos(tet)+CIK(2)*cos(2*tet)+CIK(3)*cos(3*tet)-
... 
    SIK(1)*sin(tet)-SIK(2)*sin(2*tet)-SIK(3)*cos(3*tet); % 
r=r0 
    
preds1=CIK1(1)*cos(tet)+CIK1(2)*cos(2*tet)+CIK1(3)*cos(3*tet)-
... 
    SIK1(1)*sin(tet)-SIK1(2)*sin(2*tet)-SIK1(3)*cos(3*tet); % 
r=r1 
    Preds(jt)=preds; % redukuotas skyscio slegis kai r=r0 
    Preds1(jt)=preds1; % redukuotas skyscio slegis kai r=r1     
    Predbg(jt)=dbsk*cos(tet); % red. slegis kai r=r0 
begaliniame sk. 
    Predbg1(jt)=dbsk1*cos(tet); % red. slegis kai r=r1 
begaliniame sk.     
end 
TetL; 
Preds; 
Predbg; 
  
% SLEGIS KAIP ATSTUMO FUNKCIJA (kampas tecL=const) 
Njr=1000; % Parinkti varsl=3 
rga=0.5; % cm,spindulys  
tecL=0;  % kampas 
tec=pi*tecL/180; % tas pats kampas radianais 
for jr=1:Njr 
    rs=(rn+(rga-rn)*(jr-1)/(Njr-1))/rn; % santykinis spindulys 
r/r0 
    rsa=k*rs*rn; % Beselio funkcijos argumentai kai r<r1 
    rsb=kap*rs*rn; % Beselio funkcijos argumentai, kai r>r1 
    Rs(jr)=rs; 
    if rs<(r1/rn) 
    prsc=(CCn(1)*besseli(1,rsa)-
DDn(1)*besselk(1,rsa))*cos(tec)+... % redukuotas slegis 
skystyje kaip r funkcija 
    (CCn(2)*besseli(2,rsa)-
DDn(2)*besselk(2,rsa))*cos(2*tec)+... 
    (CCn(3)*besseli(3,rsa)-DDn(3)*besselk(3,rsa))*cos(3*tec)-
... 
    (CCn(1)*besselk(1,rsa)+DDn(1)*besseli(1,rsa))*sin(tec)-... 
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    (CCn(2)*besselk(2,rsa)+DDn(2)*besseli(2,rsa))*sin(2*tec)-
... 
    (CCn(3)*besselk(3,rsa)+DDn(3)*besseli(3,rsa))*sin(3*tec); 
    Prsc(jr)=prsc; 
    else 
    
prac=(AAn(1)*besselj(1,rsb)+BBn(1)*bessely(1,rsb))*cos(tec)+..
.      
    
(AAn(2)*besselj(2,rsb)+BBn(2)*bessely(2,rsb))*cos(2*tec)+... 
    
(AAn(3)*besselj(3,rsb)+BBn(3)*bessely(3,rsb))*cos(3*tec)+... 
    (AAn(1)*bessely(1,rsb)-BBn(1)*besselj(1,rsb))*sin(tec)+... 
    (AAn(2)*bessely(2,rsb)-
BBn(2)*besselj(2,rsb))*sin(2*tec)+... 
    (AAn(3)*bessely(3,rsb)-BBn(3)*besselj(3,rsb))*sin(3*tec); 
%red. slegis audinyje kaip r funkcija, nepadaugintas is tankiu 
sant. 
    Prsc(jr)=ros*prac; % red. slegis audinyje kaip r funkcija 
    end 
    KnnF=besselk(1,rsa); % Beselio funkcija K1  
    prbga=cs*KnnF/KnnbG; % red. slegis begaliniame skystyje 
    Prbga(jr)=prbga; 
end 
Rs; 
Prsc; 
% PARINKTI varsl 
varsl=3; 
if varsl==1 
plot(TetL,Preds,TetL,Predbg,'--') 
grid on 
title('SLEGIS ANT VAMZDELIO.') 
xlabel('Kampas teta laipsniais') 
ylabel('Redukuotas slegis') 
text(-120,5000,'begaliniame skystyje') 
text(10,16000,'su kavernomis') 
end 
if varsl==2 
plot(TetL,Preds1,TetL,Predbg1,'--') 
grid on 
title('SLEGIS prie AUDINIO.') 
xlabel('Kampas teta laipsniais') 
ylabel('Redukuotas slegis') 
text(-140,1800,'begaliniame skystyje') 
text(-45,350,'su kavernomis') 
end 
if varsl==3 
plot(Rs,Prsc,Rs,Prbga,'--' ) 
grid on 
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title('SLEGIS. Punktyru - begaliniame skystyje ') 
xlabel('Santykinis atstumas r/r0') 
ylabel('Redukuotas slegis') 
text(-140,1800,'begaliniame skystyje') 
text(-45,350,'su kavernomis') 
end 
  
clear 
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